Bibliography: library/10665-360861
The reference for library/10665-360861 (who-iris) and any references extracted from it. library · All references.
Export these 112 references: BibTeX · CSL-JSON · RIS · Dublin Core XML · Dublin Core / BIBO JSON-LD
✍ + Add reference (standalone node)
112 shown
-
World Health Organization (2022). Differentiated and simplified pre-exposure prophylaxis for HIV prevention: update to WHO implementation guidance: technical brief. World Health Organization.
10665-360861· catalogue · link · repository record · ISBN 9789240053694 (electronic version) · source:catalogue/records/10665-360861.dc.json· held:library/10665-360861
export: BibTeX · RIS · CSL-JSON · DC XML -
Schaefer R, Schmidt HMA, Ravasi G, Mozalevskis A, Rewari BB, Lule F, et al. Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study. Lancet HIV. 2021;8(8):e502-e510. doi:10.1016/S2352-3018(21)00127-2
· extracted · doi:10.1016/S2352-3018(21)00127-2 · source:references/10665-360861.sec-030.1.jsonSchaefer R, Schmidt HMA, Ravasi G, Mozalevskis A, Rewari BB, Lule F, et al. Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study. Lancet HIV. 2021;8(8):e502-e510. doi:10.1016/S2352-3018(21)00127-2
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1016/S2352-3018(21)00127-2
- As printed
- Schaefer R, Schmidt HMA, Ravasi G, Mozalevskis A, Rewari BB, Lule F, et al. Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study. Lancet HIV. 2021;8(8):e502-e510. doi:10.1016/S2352-3018(21)00127-2
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.1 - provenance: extracted
- read from
references/10665-360861.sec-030.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Political declaration on HIV and AIDS: ending inequalities and getting on track to end aids by 2030. New York City, NY: United Nations General Assembly; 2021 (https://www.unaids.org/sites/default/files/media_asset/2021_political-declaration-on-hiv-and-aids_en.pdf, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.2.jsonPolitical declaration on HIV and AIDS: ending inequalities and getting on track to end aids by 2030. New York City, NY: United Nations General Assembly; 2021 (https://www.unaids.org/sites/default/files/media_asset/2021_political-declaration-on-hiv-and-aids_en.pdf, accessed 29 June 2022).
- Issued
- 2021
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Political declaration on HIV and AIDS: ending inequalities and getting on track to end aids by 2030. New York City, NY: United Nations General Assembly; 2021 (https://www.unaids.org/sites/default/files/media_asset/2021_political-declaration-on-hiv-and-aids_en.pdf, accessed 29 June 2022).
Sources
- www.unaids.org/sites/default/files/media_asset/2021_political-declaration-on-hiv-and-aids_en.pdf (canonical)
In the knowledge graph
- IRI
references/10665-360861.sec-030.2 - provenance: extracted
- read from
references/10665-360861.sec-030.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/rest/bitstreams/1451670/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.3.jsonGlobal health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/rest/bitstreams/1451670/retrieve, accessed 29 June 2022).
- Issued
- 2022
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022–2030. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/rest/bitstreams/1451670/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.3 - provenance: extracted
- read from
references/10665-360861.sec-030.3.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach, 2021 update. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/342899, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.4.jsonConsolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach, 2021 update. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/342899, accessed 29 June 2022).
- Issued
- 2021
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach, 2021 update. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/342899, accessed 29 June 2022).
Sources
- apps.who.int/iris/handle/10665/342899 (canonical)
In the knowledge graph
- IRI
references/10665-360861.sec-030.4 - provenance: extracted
- read from
references/10665-360861.sec-030.4.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Guidelines on long-acting injectable cabotegravir for HIV prevention. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/360869, accessed 11 August 2022).
· extracted · link · source:references/10665-360861.sec-030.5.json· held:library/10665-360869Guidelines on long-acting injectable cabotegravir for HIV prevention. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/360869, accessed 11 August 2022).
- Issued
- 2022
- Type
- document
- Accessed
- 11 August 2022
- As printed
- Guidelines on long-acting injectable cabotegravir for HIV prevention. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/360869, accessed 11 August 2022).
Sources
- apps.who.int/iris/handle/10665/360869 (canonical)
In the knowledge graph
- IRI
references/10665-360861.sec-030.5 - provenance: extracted
- read from
references/10665-360861.sec-030.5.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md - library copy:
library/10665-360869
-
What’s the 2+1+1? Event-driven oral pre-exposure prophylaxis to prevent HIV for men who have sex with men: update to WHO’s recommendation on oral PrEP. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/rest/bitstreams/1239070/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.6.jsonWhat’s the 2+1+1? Event-driven oral pre-exposure prophylaxis to prevent HIV for men who have sex with men: update to WHO’s recommendation on oral PrEP. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/rest/bitstreams/1239070/retrieve, accessed 29 June 2022).
- Issued
- 2019
- Type
- document
- Accessed
- 29 June 2022
- As printed
- What’s the 2+1+1? Event-driven oral pre-exposure prophylaxis to prevent HIV for men who have sex with men: update to WHO’s recommendation on oral PrEP. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/rest/bitstreams/1239070/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.6 - provenance: extracted
- read from
references/10665-360861.sec-030.6.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237-2246. doi:10.1056/NEJMoa1506273
· extracted · doi:10.1056/NEJMoa1506273 · source:references/10665-360861.sec-030.7.jsonMolina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237-2246. doi:10.1056/NEJMoa1506273
- Issued
- 2015
- Type
- article-journal
- DOI
- 10.1056/NEJMoa1506273
- As printed
- Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237-2246. doi:10.1056/NEJMoa1506273
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.7 - provenance: extracted
- read from
references/10665-360861.sec-030.7.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, et al. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV. 2017;4(9):e402-e410. doi:10.1016/S2352-3018(17)30089-9
· extracted · doi:10.1016/S2352-3018(17)30089-9 · source:references/10665-360861.sec-030.8.jsonMolina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, et al. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV. 2017;4(9):e402-e410. doi:10.1016/S2352-3018(17)30089-9
- Issued
- 2017
- Type
- article-journal
- DOI
- 10.1016/S2352-3018(17)30089-9
- As printed
- Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, et al. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV. 2017;4(9):e402-e410. doi:10.1016/S2352-3018(17)30089-9
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.8 - provenance: extracted
- read from
references/10665-360861.sec-030.8.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Hiransuthikul A, Janamnuaysook R, Himmad K, Kerr SJ, Thammajaruk N, Pankam T, et al. Drug-drug interactions between feminizing hormone therapy and pre-exposure prophylaxis among transgender women: the iFACT study. J Int AIDS Soc. 2019;22(7):e25338-e25338. doi:10.1002/jia2.25338
· extracted · doi:10.1002/jia2.25338 · source:references/10665-360861.sec-030.9.jsonHiransuthikul A, Janamnuaysook R, Himmad K, Kerr SJ, Thammajaruk N, Pankam T, et al. Drug-drug interactions between feminizing hormone therapy and pre-exposure prophylaxis among transgender women: the iFACT study. J Int AIDS Soc. 2019;22(7):e25338-e25338. doi:10.1002/jia2.25338
- Issued
- 2019
- Type
- article-journal
- DOI
- 10.1002/jia2.25338
- As printed
- Hiransuthikul A, Janamnuaysook R, Himmad K, Kerr SJ, Thammajaruk N, Pankam T, et al. Drug-drug interactions between feminizing hormone therapy and pre-exposure prophylaxis among transgender women: the iFACT study. J Int AIDS Soc. 2019;22(7):e25338-e25338. doi:10.1002/jia2.25338
Sources
- doi:10.1002/jia2.25338 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.9 - provenance: extracted
- read from
references/10665-360861.sec-030.9.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Shieh E, Marzinke MA, Fuchs EJ, Hamlin A, Bakshi R, Aung W, et al. Transgender women on oral HIV pre-exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when compared to cisgender men. J Int AIDS Soc. 2019;22(11):e25405. doi:10.1002/jia2.25405.
· extracted · doi:10.1002/jia2.25405 · source:references/10665-360861.sec-030.10.jsonShieh E, Marzinke MA, Fuchs EJ, Hamlin A, Bakshi R, Aung W, et al. Transgender women on oral HIV pre-exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when compared to cisgender men. J Int AIDS Soc. 2019;22(11):e25405. doi:10.1002/jia2.25405.
- Issued
- 2019
- Type
- article-journal
- DOI
- 10.1002/jia2.25405
- As printed
- Shieh E, Marzinke MA, Fuchs EJ, Hamlin A, Bakshi R, Aung W, et al. Transgender women on oral HIV pre-exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when compared to cisgender men. J Int AIDS Soc. 2019;22(11):e25405. doi:10.1002/jia2.25405.
Sources
- doi:10.1002/jia2.25405 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.10 - provenance: extracted
- read from
references/10665-360861.sec-030.10.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Grant RM, Pellegrini M, Defechereux PA, Anderson PL, Yu M, Glidden DV, et al. Sex hormone therapy and tenofovir diphosphate concentration in dried blood spots: primary results of the interactions between antiretrovirals and transgender hormones study. Clin Infect Dis. 2021;73(7):e2117-e2123. doi:10.1093/cid/ciaa1160
· extracted · doi:10.1093/cid/ciaa1160 · source:references/10665-360861.sec-030.11.jsonGrant RM, Pellegrini M, Defechereux PA, Anderson PL, Yu M, Glidden DV, et al. Sex hormone therapy and tenofovir diphosphate concentration in dried blood spots: primary results of the interactions between antiretrovirals and transgender hormones study. Clin Infect Dis. 2021;73(7):e2117-e2123. doi:10.1093/cid/ciaa1160
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1093/cid/ciaa1160
- As printed
- Grant RM, Pellegrini M, Defechereux PA, Anderson PL, Yu M, Glidden DV, et al. Sex hormone therapy and tenofovir diphosphate concentration in dried blood spots: primary results of the interactions between antiretrovirals and transgender hormones study. Clin Infect Dis. 2021;73(7):e2117-e2123. doi:10.1093/cid/ciaa1160
Sources
- doi:10.1093/cid/ciaa1160 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.11 - provenance: extracted
- read from
references/10665-360861.sec-030.11.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Cottrell ML, Yang KH, Prince HMA, Sykes C, White N, Malone S, et al. A translational pharmacology approach to predicting outcomes of preexposure prophylaxis against HIV in men and women using tenofovir disoproxil fumarate with or without emtricitabine. J Infect Dis. 2016;214(1):55-64. doi:10.1093/infdis/jiw077
· extracted · doi:10.1093/infdis/jiw077 · source:references/10665-360861.sec-030.12.jsonCottrell ML, Yang KH, Prince HMA, Sykes C, White N, Malone S, et al. A translational pharmacology approach to predicting outcomes of preexposure prophylaxis against HIV in men and women using tenofovir disoproxil fumarate with or without emtricitabine. J Infect Dis. 2016;214(1):55-64. doi:10.1093/infdis/jiw077
- Issued
- 2016
- Type
- article-journal
- DOI
- 10.1093/infdis/jiw077
- As printed
- Cottrell ML, Yang KH, Prince HMA, Sykes C, White N, Malone S, et al. A translational pharmacology approach to predicting outcomes of preexposure prophylaxis against HIV in men and women using tenofovir disoproxil fumarate with or without emtricitabine. J Infect Dis. 2016;214(1):55-64. doi:10.1093/infdis/jiw077
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.12 - provenance: extracted
- read from
references/10665-360861.sec-030.12.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Garrett KL, Chen J, Maas BM, Cottrell ML, Prince HA, Sykes C, et al. A pharmacokinetic/pharmacodynamic model to predict effective HIV prophylaxis dosing strategies for people who inject drugs. J Pharmacol Exp Ther. 2018;367(2):245-251. doi:10.1124/jpet.118.251009
· extracted · doi:10.1124/jpet.118.251009 · source:references/10665-360861.sec-030.13.jsonGarrett KL, Chen J, Maas BM, Cottrell ML, Prince HA, Sykes C, et al. A pharmacokinetic/pharmacodynamic model to predict effective HIV prophylaxis dosing strategies for people who inject drugs. J Pharmacol Exp Ther. 2018;367(2):245-251. doi:10.1124/jpet.118.251009
- Issued
- 2018
- Type
- article-journal
- DOI
- 10.1124/jpet.118.251009
- As printed
- Garrett KL, Chen J, Maas BM, Cottrell ML, Prince HA, Sykes C, et al. A pharmacokinetic/pharmacodynamic model to predict effective HIV prophylaxis dosing strategies for people who inject drugs. J Pharmacol Exp Ther. 2018;367(2):245-251. doi:10.1124/jpet.118.251009
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.13 - provenance: extracted
- read from
references/10665-360861.sec-030.13.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Glidden DV, Anderson PL, Grant RM. Pharmacology supports on-demand PrEP. Lancet HIV. 2016;3(9):e405-e406. doi:10.1016/S2352-3018(16)30114-X
· extracted · doi:10.1016/S2352-3018(16)30114-X · source:references/10665-360861.sec-030.14.jsonGlidden DV, Anderson PL, Grant RM. Pharmacology supports on-demand PrEP. Lancet HIV. 2016;3(9):e405-e406. doi:10.1016/S2352-3018(16)30114-X
- Issued
- 2016
- Type
- article-journal
- DOI
- 10.1016/S2352-3018(16)30114-X
- As printed
- Glidden DV, Anderson PL, Grant RM. Pharmacology supports on-demand PrEP. Lancet HIV. 2016;3(9):e405-e406. doi:10.1016/S2352-3018(16)30114-X
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.14 - provenance: extracted
- read from
references/10665-360861.sec-030.14.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Iannuzzi S, von Kleist M. Mathematical modelling of the molecular mechanisms of interaction of tenofovir with emtricitabine against HIV. Viruses. 2021;13(7):1354. doi:10.3390/v13071354
· extracted · doi:10.3390/v13071354 · source:references/10665-360861.sec-030.15.jsonIannuzzi S, von Kleist M. Mathematical modelling of the molecular mechanisms of interaction of tenofovir with emtricitabine against HIV. Viruses. 2021;13(7):1354. doi:10.3390/v13071354
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.3390/v13071354
- As printed
- Iannuzzi S, von Kleist M. Mathematical modelling of the molecular mechanisms of interaction of tenofovir with emtricitabine against HIV. Viruses. 2021;13(7):1354. doi:10.3390/v13071354
Sources
- doi:10.3390/v13071354 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.15 - provenance: extracted
- read from
references/10665-360861.sec-030.15.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Patterson KB, Prince HA, Kraft E, Jenkins AJ, Shaheen NJ, Rooney JF, et al. Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med. 2011;3(112):112re4-112re4. doi:10.1126/scitranslmed.3003174
· extracted · doi:10.1126/scitranslmed.3003174 · source:references/10665-360861.sec-030.16.jsonPatterson KB, Prince HA, Kraft E, Jenkins AJ, Shaheen NJ, Rooney JF, et al. Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med. 2011;3(112):112re4-112re4. doi:10.1126/scitranslmed.3003174
- Issued
- 2011
- Type
- article-journal
- DOI
- 10.1126/scitranslmed.3003174
- As printed
- Patterson KB, Prince HA, Kraft E, Jenkins AJ, Shaheen NJ, Rooney JF, et al. Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med. 2011;3(112):112re4-112re4. doi:10.1126/scitranslmed.3003174
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.16 - provenance: extracted
- read from
references/10665-360861.sec-030.16.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Dickinson L, Yapa HM, Jackson A, Moyle G, Else L, Amara A, et al. Plasma tenofovir, emtricitabine, and rilpivirine and intracellular tenofovir diphosphate and emtricitabine triphosphate pharmacokinetics following drug intake cessation. Antimicrob Agents Chemother. 2015;59(10):6080-6086. doi:10.1128/AAC.01441-15
· extracted · doi:10.1128/AAC.01441-15 · source:references/10665-360861.sec-030.17.jsonDickinson L, Yapa HM, Jackson A, Moyle G, Else L, Amara A, et al. Plasma tenofovir, emtricitabine, and rilpivirine and intracellular tenofovir diphosphate and emtricitabine triphosphate pharmacokinetics following drug intake cessation. Antimicrob Agents Chemother. 2015;59(10):6080-6086. doi:10.1128/AAC.01441-15
- Issued
- 2015
- Type
- article-journal
- DOI
- 10.1128/AAC.01441-15
- As printed
- Dickinson L, Yapa HM, Jackson A, Moyle G, Else L, Amara A, et al. Plasma tenofovir, emtricitabine, and rilpivirine and intracellular tenofovir diphosphate and emtricitabine triphosphate pharmacokinetics following drug intake cessation. Antimicrob Agents Chemother. 2015;59(10):6080-6086. doi:10.1128/AAC.01441-15
Sources
- doi:10.1128/AAC.01441-15 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.17 - provenance: extracted
- read from
references/10665-360861.sec-030.17.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Cottrell ML, Srinivas N, Kashuba ADM. Pharmacokinetics of antiretrovirals in mucosal tissue. Expert Opin Drug Metab Toxicol. 2015;11(6):893-905. doi:10.1517/17425255.2015. 1027682
· extracted · doi:10.1517/17425255.2015 · source:references/10665-360861.sec-030.18.jsonCottrell ML, Srinivas N, Kashuba ADM. Pharmacokinetics of antiretrovirals in mucosal tissue. Expert Opin Drug Metab Toxicol. 2015;11(6):893-905. doi:10.1517/17425255.2015. 1027682
- Issued
- 2015
- Type
- article-journal
- DOI
- 10.1517/17425255.2015
- As printed
- Cottrell ML, Srinivas N, Kashuba ADM. Pharmacokinetics of antiretrovirals in mucosal tissue. Expert Opin Drug Metab Toxicol. 2015;11(6):893-905. doi:10.1517/17425255.2015. 1027682
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.18 - provenance: extracted
- read from
references/10665-360861.sec-030.18.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Duwal S, Sunkara V, von Kleist M. Multiscale systems-pharmacology pipeline to assess the prophylactic efficacy of NRTIs against HIV-1. CPT Pharmacometrics Syst Pharmacol. 2016;5(7):377-387. doi:10.1002/psp4.12095
· extracted · doi:10.1002/psp4.12095 · source:references/10665-360861.sec-030.19.jsonDuwal S, Sunkara V, von Kleist M. Multiscale systems-pharmacology pipeline to assess the prophylactic efficacy of NRTIs against HIV-1. CPT Pharmacometrics Syst Pharmacol. 2016;5(7):377-387. doi:10.1002/psp4.12095
- Issued
- 2016
- Type
- article-journal
- DOI
- 10.1002/psp4.12095
- As printed
- Duwal S, Sunkara V, von Kleist M. Multiscale systems-pharmacology pipeline to assess the prophylactic efficacy of NRTIs against HIV-1. CPT Pharmacometrics Syst Pharmacol. 2016;5(7):377-387. doi:10.1002/psp4.12095
Sources
- doi:10.1002/psp4.12095 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.19 - provenance: extracted
- read from
references/10665-360861.sec-030.19.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Ford N, Irvine C, Shubber Z, Baggaley R, Beanland R, Vitoria M, et al. Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysis. AIDS. 2014;28(18). doi:10.1097/QAD.0000000000000505
· extracted · doi:10.1097/QAD.0000000000000505 · source:references/10665-360861.sec-030.20.jsonFord N, Irvine C, Shubber Z, Baggaley R, Beanland R, Vitoria M, et al. Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysis. AIDS. 2014;28(18). doi:10.1097/QAD.0000000000000505
- Issued
- 2014
- Type
- document
- DOI
- 10.1097/QAD.0000000000000505
- As printed
- Ford N, Irvine C, Shubber Z, Baggaley R, Beanland R, Vitoria M, et al. Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysis. AIDS. 2014;28(18). doi:10.1097/QAD.0000000000000505
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.20 - provenance: extracted
- read from
references/10665-360861.sec-030.20.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Saag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA panel. JAMA. 2020;324(16):1651-1669. doi:10.1001/jama.2020.17025
· extracted · doi:10.1001/jama.2020.17025 · source:references/10665-360861.sec-030.21.jsonSaag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA panel. JAMA. 2020;324(16):1651-1669. doi:10.1001/jama.2020.17025
- Issued
- 2020
- Type
- article-journal
- DOI
- 10.1001/jama.2020.17025
- As printed
- Saag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA panel. JAMA. 2020;324(16):1651-1669. doi:10.1001/jama.2020.17025
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.21 - provenance: extracted
- read from
references/10665-360861.sec-030.21.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018. Letchworth; Macclesfield: British HIV Association (BHIVA); British Association for Sexual Health and HIV (BASHH); 2018 (https://www.bhiva.org/PrEP-guidelines, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.22.jsonBHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018. Letchworth; Macclesfield: British HIV Association (BHIVA); British Association for Sexual Health and HIV (BASHH); 2018 (https://www.bhiva.org/PrEP-guidelines, accessed 29 June 2022).
- Issued
- 2018
- Type
- document
- Accessed
- 29 June 2022
- As printed
- BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018. Letchworth; Macclesfield: British HIV Association (BHIVA); British Association for Sexual Health and HIV (BASHH); 2018 (https://www.bhiva.org/PrEP-guidelines, accessed 29 June 2022).
Sources
- www.bhiva.org/PrEP-guidelines (canonical)
In the knowledge graph
- IRI
references/10665-360861.sec-030.22 - provenance: extracted
- read from
references/10665-360861.sec-030.22.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
EACS guidelines version 11.0, October 2021. Brussels: European AIDS Clinical Society (EACS); 2021 (https://www.eacsociety.org/guidelines/eacs-guidelines/, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.23.jsonEACS guidelines version 11.0, October 2021. Brussels: European AIDS Clinical Society (EACS); 2021 (https://www.eacsociety.org/guidelines/eacs-guidelines/, accessed 29 June 2022).
- Issued
- 2021
- Type
- document
- Accessed
- 29 June 2022
- As printed
- EACS guidelines version 11.0, October 2021. Brussels: European AIDS Clinical Society (EACS); 2021 (https://www.eacsociety.org/guidelines/eacs-guidelines/, accessed 29 June 2022).
Sources
- www.eacsociety.org/guidelines/eacs-guidelines/ (canonical)
In the knowledge graph
- IRI
references/10665-360861.sec-030.23 - provenance: extracted
- read from
references/10665-360861.sec-030.23.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Preexposure prophylaxis for the prevention of HIV infection in the United States–2021 update: a clinical practice guideline. Atlanta: Centers for Disease Control and Prevention: US Public Health Service; 2021 (https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.24.jsonPreexposure prophylaxis for the prevention of HIV infection in the United States–2021 update: a clinical practice guideline. Atlanta: Centers for Disease Control and Prevention: US Public Health Service; 2021 (https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf, accessed 29 June 2022).
- Issued
- 2021
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Preexposure prophylaxis for the prevention of HIV infection in the United States–2021 update: a clinical practice guideline. Atlanta: Centers for Disease Control and Prevention: US Public Health Service; 2021 (https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.24 - provenance: extracted
- read from
references/10665-360861.sec-030.24.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
World Health Organization. Hepatitis B vaccines: WHO position paper – July 2017. Wkly Epidemiol Rec. 2017;92(27):369–392. (https://apps.who.int/iris/handle/10665/255873, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.25.jsonWorld Health Organization. Hepatitis B vaccines: WHO position paper – July 2017. Wkly Epidemiol Rec. 2017;92(27):369–392. (https://apps.who.int/iris/handle/10665/255873, accessed 29 June 2022).
- Issued
- 2017
- Type
- article-journal
- Accessed
- 29 June 2022
- As printed
- World Health Organization. Hepatitis B vaccines: WHO position paper – July 2017. Wkly Epidemiol Rec. 2017;92(27):369–392. (https://apps.who.int/iris/handle/10665/255873, accessed 29 June 2022).
Sources
- apps.who.int/iris/handle/10665/255873 (canonical)
In the knowledge graph
- IRI
references/10665-360861.sec-030.25 - provenance: extracted
- read from
references/10665-360861.sec-030.25.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015 (https://apps.who.int/iris/rest/bitstreams/688548/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.26.jsonGuidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015 (https://apps.who.int/iris/rest/bitstreams/688548/retrieve, accessed 29 June 2022).
- Issued
- 2015
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015 (https://apps.who.int/iris/rest/bitstreams/688548/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.26 - provenance: extracted
- read from
references/10665-360861.sec-030.26.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and HCV diagnostics. Geneva: World Health Organization; 2022.
· extracted · source:references/10665-360861.sec-030.27.jsonUpdated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and HCV diagnostics. Geneva: World Health Organization; 2022.
- Issued
- 2022
- Type
- document
- As printed
- Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and HCV diagnostics. Geneva: World Health Organization; 2022.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-360861.sec-030.27 - provenance: extracted
- read from
references/10665-360861.sec-030.27.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/bitstream/handle/10665/360601/9789240052390-eng.pdf, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.28.json· held:library/10665-360601Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/bitstream/handle/10665/360601/9789240052390-eng.pdf, accessed 29 June 2022).
- Issued
- 2022
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/bitstream/handle/10665/360601/9789240052390-eng.pdf, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.28 - provenance: extracted
- read from
references/10665-360861.sec-030.28.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md - library copy:
library/10665-360601
-
Recommendations and guidance on hepatitis C virus self-testing. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/rest/bitstreams/1356715/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.29.jsonRecommendations and guidance on hepatitis C virus self-testing. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/rest/bitstreams/1356715/retrieve, accessed 29 June 2022).
- Issued
- 2021
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Recommendations and guidance on hepatitis C virus self-testing. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/rest/bitstreams/1356715/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.29 - provenance: extracted
- read from
references/10665-360861.sec-030.29.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Geneva: World Health Organization; 2018 (https://apps.who.int/iris/rest/bitstreams/1141441/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.30.jsonGuidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Geneva: World Health Organization; 2018 (https://apps.who.int/iris/rest/bitstreams/1141441/retrieve, accessed 29 June 2022).
- Issued
- 2018
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Geneva: World Health Organization; 2018 (https://apps.who.int/iris/rest/bitstreams/1141441/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.30 - provenance: extracted
- read from
references/10665-360861.sec-030.30.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Progress report on HIV, viral hepatitis and sexually transmitted infections 2021: accountability for the global health sector strategies, 2016–2021: actions for impact. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/rest/bitstreams/1348210/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.31.jsonProgress report on HIV, viral hepatitis and sexually transmitted infections 2021: accountability for the global health sector strategies, 2016–2021: actions for impact. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/rest/bitstreams/1348210/retrieve, accessed 29 June 2022).
- Issued
- 2021
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Progress report on HIV, viral hepatitis and sexually transmitted infections 2021: accountability for the global health sector strategies, 2016–2021: actions for impact. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/rest/bitstreams/1348210/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.31 - provenance: extracted
- read from
references/10665-360861.sec-030.31.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Global health sector strategy on viral hepatitis 2016–2021: towards ending viral hepatitis. Geneva: World Health Organization; 2016 (https://apps.who.int/iris/rest/bitstreams/1031495/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.32.jsonGlobal health sector strategy on viral hepatitis 2016–2021: towards ending viral hepatitis. Geneva: World Health Organization; 2016 (https://apps.who.int/iris/rest/bitstreams/1031495/retrieve, accessed 29 June 2022).
- Issued
- 2016
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Global health sector strategy on viral hepatitis 2016–2021: towards ending viral hepatitis. Geneva: World Health Organization; 2016 (https://apps.who.int/iris/rest/bitstreams/1031495/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.32 - provenance: extracted
- read from
references/10665-360861.sec-030.32.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Peterson L, Taylor D, Roddy R, Belai G, Phillips P, Nanda K, et al. Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials. 2007;2(5):e27-e27. doi:10.1371/journal.pctr.0020027
· extracted · doi:10.1371/journal.pctr.0020027 · source:references/10665-360861.sec-030.33.jsonPeterson L, Taylor D, Roddy R, Belai G, Phillips P, Nanda K, et al. Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials. 2007;2(5):e27-e27. doi:10.1371/journal.pctr.0020027
- Issued
- 2007
- Type
- article-journal
- DOI
- 10.1371/journal.pctr.0020027
- As printed
- Peterson L, Taylor D, Roddy R, Belai G, Phillips P, Nanda K, et al. Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials. 2007;2(5):e27-e27. doi:10.1371/journal.pctr.0020027
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.33 - provenance: extracted
- read from
references/10665-360861.sec-030.33.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587-2599. doi:10.1056/NEJMoa1011205
· extracted · doi:10.1056/NEJMoa1011205 · source:references/10665-360861.sec-030.34.jsonGrant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587-2599. doi:10.1056/NEJMoa1011205
- Issued
- 2010
- Type
- article-journal
- DOI
- 10.1056/NEJMoa1011205
- As printed
- Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587-2599. doi:10.1056/NEJMoa1011205
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.34 - provenance: extracted
- read from
references/10665-360861.sec-030.34.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Solomon MM, Schechter M, Liu AY, McMahan VM, Guanira J V, Hance RJ, et al. The safety of tenofovir-emtricitabine for HIV pre-exposure prophylaxis (PrEP) in individuals with active hepatitis B. J Acquir Immune Defic Syndr. 2016;71(3):281-286. doi:10.1097/QAI.0000000000000857
· extracted · doi:10.1097/QAI.0000000000000857 · source:references/10665-360861.sec-030.35.jsonSolomon MM, Schechter M, Liu AY, McMahan VM, Guanira J V, Hance RJ, et al. The safety of tenofovir-emtricitabine for HIV pre-exposure prophylaxis (PrEP) in individuals with active hepatitis B. J Acquir Immune Defic Syndr. 2016;71(3):281-286. doi:10.1097/QAI.0000000000000857
- Issued
- 2016
- Type
- article-journal
- DOI
- 10.1097/QAI.0000000000000857
- As printed
- Solomon MM, Schechter M, Liu AY, McMahan VM, Guanira J V, Hance RJ, et al. The safety of tenofovir-emtricitabine for HIV pre-exposure prophylaxis (PrEP) in individuals with active hepatitis B. J Acquir Immune Defic Syndr. 2016;71(3):281-286. doi:10.1097/QAI.0000000000000857
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.35 - provenance: extracted
- read from
references/10665-360861.sec-030.35.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Ghany MG, Feld JJ, Chang KM, Chan HLY, Lok ASF, Visvanathan K, et al. Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad. Lancet Gastroenterol Hepatol. 2020;5(4):406-417. doi:10.1016/S2468-1253(19)30344-9
· extracted · doi:10.1016/S2468-1253(19)30344-9 · source:references/10665-360861.sec-030.36.jsonGhany MG, Feld JJ, Chang KM, Chan HLY, Lok ASF, Visvanathan K, et al. Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad. Lancet Gastroenterol Hepatol. 2020;5(4):406-417. doi:10.1016/S2468-1253(19)30344-9
- Issued
- 2020
- Type
- article-journal
- DOI
- 10.1016/S2468-1253(19)30344-9
- As printed
- Ghany MG, Feld JJ, Chang KM, Chan HLY, Lok ASF, Visvanathan K, et al. Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad. Lancet Gastroenterol Hepatol. 2020;5(4):406-417. doi:10.1016/S2468-1253(19)30344-9
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.36 - provenance: extracted
- read from
references/10665-360861.sec-030.36.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Kitrinos KM, Corsa A, Liu Y, Flaherty J, Snow-Lampart A, Marcellin P, et al. No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B. Hepatology. 2014;59(2):434-442. doi:10.1002/hep.26686
· extracted · doi:10.1002/hep.26686 · source:references/10665-360861.sec-030.37.jsonKitrinos KM, Corsa A, Liu Y, Flaherty J, Snow-Lampart A, Marcellin P, et al. No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B. Hepatology. 2014;59(2):434-442. doi:10.1002/hep.26686
- Issued
- 2014
- Type
- article-journal
- DOI
- 10.1002/hep.26686
- As printed
- Kitrinos KM, Corsa A, Liu Y, Flaherty J, Snow-Lampart A, Marcellin P, et al. No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B. Hepatology. 2014;59(2):434-442. doi:10.1002/hep.26686
Sources
- doi:10.1002/hep.26686 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.37 - provenance: extracted
- read from
references/10665-360861.sec-030.37.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Liu Y, Corsa AC, Buti M, Cathcart AL, Flaherty JF, Miller MD, et al. No detectable resistance to tenofovir disoproxil fumarate in HBeAg+ and HBeAg− patients with chronic hepatitis B after 8 years of treatment. J Viral Hepat. 2017;24(1):68-74. doi:10.1111/jvh.12613
· extracted · doi:10.1111/jvh.12613 · source:references/10665-360861.sec-030.38.jsonLiu Y, Corsa AC, Buti M, Cathcart AL, Flaherty JF, Miller MD, et al. No detectable resistance to tenofovir disoproxil fumarate in HBeAg+ and HBeAg− patients with chronic hepatitis B after 8 years of treatment. J Viral Hepat. 2017;24(1):68-74. doi:10.1111/jvh.12613
- Issued
- 2017
- Type
- article-journal
- DOI
- 10.1111/jvh.12613
- As printed
- Liu Y, Corsa AC, Buti M, Cathcart AL, Flaherty JF, Miller MD, et al. No detectable resistance to tenofovir disoproxil fumarate in HBeAg+ and HBeAg− patients with chronic hepatitis B after 8 years of treatment. J Viral Hepat. 2017;24(1):68-74. doi:10.1111/jvh.12613
Sources
- doi:10.1111/jvh.12613 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.38 - provenance: extracted
- read from
references/10665-360861.sec-030.38.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Marcellin P, Wong DK, Sievert W, Buggisch P, Petersen J, Flisiak R, et al. Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection. Liver Int. 2019;39(10):1868-1875. doi:10.1111/liv.14155
· extracted · doi:10.1111/liv.14155 · source:references/10665-360861.sec-030.39.jsonMarcellin P, Wong DK, Sievert W, Buggisch P, Petersen J, Flisiak R, et al. Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection. Liver Int. 2019;39(10):1868-1875. doi:10.1111/liv.14155
- Issued
- 2019
- Type
- article-journal
- DOI
- 10.1111/liv.14155
- As printed
- Marcellin P, Wong DK, Sievert W, Buggisch P, Petersen J, Flisiak R, et al. Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection. Liver Int. 2019;39(10):1868-1875. doi:10.1111/liv.14155
Sources
- doi:10.1111/liv.14155 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.39 - provenance: extracted
- read from
references/10665-360861.sec-030.39.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/bitstream/handle/10665/333391/9789240002708-eng.pdf, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.40.jsonPrevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/bitstream/handle/10665/333391/9789240002708-eng.pdf, accessed 29 June 2022).
- Issued
- 2020
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/bitstream/handle/10665/333391/9789240002708-eng.pdf, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.40 - provenance: extracted
- read from
references/10665-360861.sec-030.40.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Diagnosis and management of type 2 diabetes (HEARTS D). Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1274478/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.41.jsonDiagnosis and management of type 2 diabetes (HEARTS D). Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1274478/retrieve, accessed 29 June 2022).
- Issued
- 2020
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Diagnosis and management of type 2 diabetes (HEARTS D). Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1274478/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.41 - provenance: extracted
- read from
references/10665-360861.sec-030.41.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737-1749. doi:10.1056/NEJMoa2102953
· extracted · doi:10.1056/NEJMoa2102953 · source:references/10665-360861.sec-030.42.jsonInker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737-1749. doi:10.1056/NEJMoa2102953
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1056/NEJMoa2102953
- As printed
- Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737-1749. doi:10.1056/NEJMoa2102953
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.42 - provenance: extracted
- read from
references/10665-360861.sec-030.42.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Patel N, Blumenthal J, Dubé MP, Hood A, Bolan R, Morris S. Method of calculating renal function estimates could inappropriately exclude transgender patients receiving gender-affirming hormone therapy from pre-exposure prophylaxis eligibility. LGBT Health. 2022;9(3):199-206. doi:10.1089/lgbt.2021.0219
· extracted · doi:10.1089/lgbt.2021.0219 · source:references/10665-360861.sec-030.43.jsonPatel N, Blumenthal J, Dubé MP, Hood A, Bolan R, Morris S. Method of calculating renal function estimates could inappropriately exclude transgender patients receiving gender-affirming hormone therapy from pre-exposure prophylaxis eligibility. LGBT Health. 2022;9(3):199-206. doi:10.1089/lgbt.2021.0219
- Issued
- 2022
- Type
- article-journal
- DOI
- 10.1089/lgbt.2021.0219
- As printed
- Patel N, Blumenthal J, Dubé MP, Hood A, Bolan R, Morris S. Method of calculating renal function estimates could inappropriately exclude transgender patients receiving gender-affirming hormone therapy from pre-exposure prophylaxis eligibility. LGBT Health. 2022;9(3):199-206. doi:10.1089/lgbt.2021.0219
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.43 - provenance: extracted
- read from
references/10665-360861.sec-030.43.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Webb AJ, McManus D, Rouse GE, Vonderheyde R, Topal JE. Implications for medication dosing for transgender patients: a review of the literature and recommendations for pharmacists. Am J Health Syst Pharm. 2020;77(6):427-433. doi:10.1093/ajhp/zxz355
· extracted · doi:10.1093/ajhp/zxz355 · source:references/10665-360861.sec-030.44.jsonWebb AJ, McManus D, Rouse GE, Vonderheyde R, Topal JE. Implications for medication dosing for transgender patients: a review of the literature and recommendations for pharmacists. Am J Health Syst Pharm. 2020;77(6):427-433. doi:10.1093/ajhp/zxz355
- Issued
- 2020
- Type
- article-journal
- DOI
- 10.1093/ajhp/zxz355
- As printed
- Webb AJ, McManus D, Rouse GE, Vonderheyde R, Topal JE. Implications for medication dosing for transgender patients: a review of the literature and recommendations for pharmacists. Am J Health Syst Pharm. 2020;77(6):427-433. doi:10.1093/ajhp/zxz355
Sources
- doi:10.1093/ajhp/zxz355 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.44 - provenance: extracted
- read from
references/10665-360861.sec-030.44.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Gao M, Vilayur E, Ferreira D, Nanra R, Hawkins J. Estimating the glomerular filtration rate in pregnancy: the evaluation of the Nanra and CKD-EPI serum creatinine-based equations. Obstet Med. 2021;14(1):31-34. doi:10.1177/1753495X20904177
· extracted · doi:10.1177/1753495X20904177 · source:references/10665-360861.sec-030.45.jsonGao M, Vilayur E, Ferreira D, Nanra R, Hawkins J. Estimating the glomerular filtration rate in pregnancy: the evaluation of the Nanra and CKD-EPI serum creatinine-based equations. Obstet Med. 2021;14(1):31-34. doi:10.1177/1753495X20904177
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1177/1753495X20904177
- As printed
- Gao M, Vilayur E, Ferreira D, Nanra R, Hawkins J. Estimating the glomerular filtration rate in pregnancy: the evaluation of the Nanra and CKD-EPI serum creatinine-based equations. Obstet Med. 2021;14(1):31-34. doi:10.1177/1753495X20904177
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.45 - provenance: extracted
- read from
references/10665-360861.sec-030.45.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Schaefer R, Amparo da Costa Leite PH, Silva R, Abdool Karim Q, Akolo C, Cáceres CF, et al. Kidney function in tenofovir disoproxil fumarate-based oral pre-exposure prophylaxis users: a systematic review and meta-analysis of published literature and a multi-country meta-analysis of individual participant data. Lancet HIV. 2022;9(4):e242-e253. doi:10.1016/S2352-3018(22)00004-2
· extracted · doi:10.1016/S2352-3018(22)00004-2 · source:references/10665-360861.sec-030.46.jsonSchaefer R, Amparo da Costa Leite PH, Silva R, Abdool Karim Q, Akolo C, Cáceres CF, et al. Kidney function in tenofovir disoproxil fumarate-based oral pre-exposure prophylaxis users: a systematic review and meta-analysis of published literature and a multi-country meta-analysis of individual participant data. Lancet HIV. 2022;9(4):e242-e253. doi:10.1016/S2352-3018(22)00004-2
- Issued
- 2022
- Type
- article-journal
- DOI
- 10.1016/S2352-3018(22)00004-2
- As printed
- Schaefer R, Amparo da Costa Leite PH, Silva R, Abdool Karim Q, Akolo C, Cáceres CF, et al. Kidney function in tenofovir disoproxil fumarate-based oral pre-exposure prophylaxis users: a systematic review and meta-analysis of published literature and a multi-country meta-analysis of individual participant data. Lancet HIV. 2022;9(4):e242-e253. doi:10.1016/S2352-3018(22)00004-2
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.46 - provenance: extracted
- read from
references/10665-360861.sec-030.46.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Pilkington V, Hill A, Hughes S, Nwokolo N, Pozniak A. How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP. J Virus Erad. 2018;4(4):215-224. doi:10.1016/S2055-6640(20)30312-5
· extracted · doi:10.1016/S2055-6640(20)30312-5 · source:references/10665-360861.sec-030.47.jsonPilkington V, Hill A, Hughes S, Nwokolo N, Pozniak A. How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP. J Virus Erad. 2018;4(4):215-224. doi:10.1016/S2055-6640(20)30312-5
- Issued
- 2018
- Type
- article-journal
- DOI
- 10.1016/S2055-6640(20)30312-5
- As printed
- Pilkington V, Hill A, Hughes S, Nwokolo N, Pozniak A. How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP. J Virus Erad. 2018;4(4):215-224. doi:10.1016/S2055-6640(20)30312-5
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.47 - provenance: extracted
- read from
references/10665-360861.sec-030.47.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Chou R, Evans C, Hoverman A, Sun C, Dana T, Bougatsos C, et al. Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2019;321(22):2214-2230. doi:10.1001/jama.2019.2591
· extracted · doi:10.1001/jama.2019.2591 · source:references/10665-360861.sec-030.48.jsonChou R, Evans C, Hoverman A, Sun C, Dana T, Bougatsos C, et al. Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2019;321(22):2214-2230. doi:10.1001/jama.2019.2591
- Issued
- 2019
- Type
- article-journal
- DOI
- 10.1001/jama.2019.2591
- As printed
- Chou R, Evans C, Hoverman A, Sun C, Dana T, Bougatsos C, et al. Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2019;321(22):2214-2230. doi:10.1001/jama.2019.2591
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.48 - provenance: extracted
- read from
references/10665-360861.sec-030.48.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Technical Specifications Series for submission to WHO prequalification – Diagnostic assessment: human immunodeficiency virus (HIV) rapid diagnostic tests for professional use and/or self-testing. Geneva: World Health Organization; 2016 (https://apps.who.int/iris/bitstream/handle/10665/251857/9789241511742-eng.pdf, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.49.jsonTechnical Specifications Series for submission to WHO prequalification – Diagnostic assessment: human immunodeficiency virus (HIV) rapid diagnostic tests for professional use and/or self-testing. Geneva: World Health Organization; 2016 (https://apps.who.int/iris/bitstream/handle/10665/251857/9789241511742-eng.pdf, accessed 29 June 2022).
- Issued
- 2016
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Technical Specifications Series for submission to WHO prequalification – Diagnostic assessment: human immunodeficiency virus (HIV) rapid diagnostic tests for professional use and/or self-testing. Geneva: World Health Organization; 2016 (https://apps.who.int/iris/bitstream/handle/10665/251857/9789241511742-eng.pdf, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.49 - provenance: extracted
- read from
references/10665-360861.sec-030.49.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Figueroa C, Johnson C, Ford N, Sands A, Dalal S, Meurant R, et al. Reliability of HIV rapid diagnostic tests for self-testing compared with testing by health-care workers: a systematic review and meta-analysis. Lancet HIV. 2018;5(6):e277-e290. doi:10.1016/S2352-3018(18)30044-4
· extracted · doi:10.1016/S2352-3018(18)30044-4 · source:references/10665-360861.sec-030.50.jsonFigueroa C, Johnson C, Ford N, Sands A, Dalal S, Meurant R, et al. Reliability of HIV rapid diagnostic tests for self-testing compared with testing by health-care workers: a systematic review and meta-analysis. Lancet HIV. 2018;5(6):e277-e290. doi:10.1016/S2352-3018(18)30044-4
- Issued
- 2018
- Type
- article-journal
- DOI
- 10.1016/S2352-3018(18)30044-4
- As printed
- Figueroa C, Johnson C, Ford N, Sands A, Dalal S, Meurant R, et al. Reliability of HIV rapid diagnostic tests for self-testing compared with testing by health-care workers: a systematic review and meta-analysis. Lancet HIV. 2018;5(6):e277-e290. doi:10.1016/S2352-3018(18)30044-4
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.50 - provenance: extracted
- read from
references/10665-360861.sec-030.50.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Maintaining essential health services: operational guidance for the COVID-19 context. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1279080/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.51.jsonMaintaining essential health services: operational guidance for the COVID-19 context. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1279080/retrieve, accessed 29 June 2022).
- Issued
- 2020
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Maintaining essential health services: operational guidance for the COVID-19 context. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1279080/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.51 - provenance: extracted
- read from
references/10665-360861.sec-030.51.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Kiptinness C, Kuo A, Reedy A, Johnson C, Ngure K, Wagner A, et al. Examining the use of HIV self-testing to support PrEP delivery: a systematic literature review. 2022 [Submitted].
· extracted · source:references/10665-360861.sec-030.52.jsonKiptinness C, Kuo A, Reedy A, Johnson C, Ngure K, Wagner A, et al. Examining the use of HIV self-testing to support PrEP delivery: a systematic literature review. 2022 [Submitted].
- Issued
- 2022
- Type
- document
- As printed
- Kiptinness C, Kuo A, Reedy A, Johnson C, Ngure K, Wagner A, et al. Examining the use of HIV self-testing to support PrEP delivery: a systematic literature review. 2022 [Submitted].
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-360861.sec-030.52 - provenance: extracted
- read from
references/10665-360861.sec-030.52.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection. Module 10: testing. Geneva: World Health Organization; 2017 (https://apps.who.int/iris/bitstream/handle/10665/258516/WHO-HIV-2017.30-eng.pdf?sequence=1, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.53.json· held:library/10665-258516WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection. Module 10: testing. Geneva: World Health Organization; 2017 (https://apps.who.int/iris/bitstream/handle/10665/258516/WHO-HIV-2017.30-eng.pdf?sequence=1, accessed 29 June 2022).
- Issued
- 2017
- Type
- document
- Accessed
- 29 June 2022
- As printed
- WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection. Module 10: testing. Geneva: World Health Organization; 2017 (https://apps.who.int/iris/bitstream/handle/10665/258516/WHO-HIV-2017.30-eng.pdf?sequence=1, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.53 - provenance: extracted
- read from
references/10665-360861.sec-030.53.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md - library copy:
library/10665-258516
-
Shahmanesh M, Mthiyane TN, Herbsst C, Neuman M, Adeagbo O, Mee P, et al. Effect of peer-distributed HIV self-test kits on demand for biomedical HIV prevention in rural Kwazulu-Natal, South Africa: a three-armed cluster-randomised trial comparing social networks versus direct delivery. BMJ Glob Health. 2021;6(Suppl 4):e004574. doi:10.1136/bmjgh-2020-004574
· extracted · doi:10.1136/bmjgh-2020-004574 · source:references/10665-360861.sec-030.54.jsonShahmanesh M, Mthiyane TN, Herbsst C, Neuman M, Adeagbo O, Mee P, et al. Effect of peer-distributed HIV self-test kits on demand for biomedical HIV prevention in rural Kwazulu-Natal, South Africa: a three-armed cluster-randomised trial comparing social networks versus direct delivery. BMJ Glob Health. 2021;6(Suppl 4):e004574. doi:10.1136/bmjgh-2020-004574
- Issued
- 2020
- Type
- document
- DOI
- 10.1136/bmjgh-2020-004574
- As printed
- Shahmanesh M, Mthiyane TN, Herbsst C, Neuman M, Adeagbo O, Mee P, et al. Effect of peer-distributed HIV self-test kits on demand for biomedical HIV prevention in rural Kwazulu-Natal, South Africa: a three-armed cluster-randomised trial comparing social networks versus direct delivery. BMJ Glob Health. 2021;6(Suppl 4):e004574. doi:10.1136/bmjgh-2020-004574
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.54 - provenance: extracted
- read from
references/10665-360861.sec-030.54.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Adeagbo OA, Seeley J, Gumede D, Xulu S, Dlamini N, Luthuli M, et al. Process evaluation of peer-to-peer delivery of HIV self-testing and sexual health information to support HIV prevention among youth in rural Kwazulu-Natal, South Africa: qualitative analysis. BMJ Open. 2022;12(2):e048780-e048780. doi:10.1136/bmjopen-2021-048780
· extracted · doi:10.1136/bmjopen-2021-048780 · source:references/10665-360861.sec-030.55.jsonAdeagbo OA, Seeley J, Gumede D, Xulu S, Dlamini N, Luthuli M, et al. Process evaluation of peer-to-peer delivery of HIV self-testing and sexual health information to support HIV prevention among youth in rural Kwazulu-Natal, South Africa: qualitative analysis. BMJ Open. 2022;12(2):e048780-e048780. doi:10.1136/bmjopen-2021-048780
- Issued
- 2022
- Type
- article-journal
- DOI
- 10.1136/bmjopen-2021-048780
- As printed
- Adeagbo OA, Seeley J, Gumede D, Xulu S, Dlamini N, Luthuli M, et al. Process evaluation of peer-to-peer delivery of HIV self-testing and sexual health information to support HIV prevention among youth in rural Kwazulu-Natal, South Africa: qualitative analysis. BMJ Open. 2022;12(2):e048780-e048780. doi:10.1136/bmjopen-2021-048780
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.55 - provenance: extracted
- read from
references/10665-360861.sec-030.55.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
HIV drug resistance surveillance in countries scaling up pre-exposure prophylaxis. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1315098/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.56.jsonHIV drug resistance surveillance in countries scaling up pre-exposure prophylaxis. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1315098/retrieve, accessed 29 June 2022).
- Issued
- 2020
- Type
- document
- Accessed
- 29 June 2022
- As printed
- HIV drug resistance surveillance in countries scaling up pre-exposure prophylaxis. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1315098/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.56 - provenance: extracted
- read from
references/10665-360861.sec-030.56.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Sanders EJ, Wahome E, Powers KA, Werner L, Fegan G, Lavreys L, et al. Targeted screening of at-risk adults for acute HIV-1 infection in sub-Saharan Africa. AIDS. 2015;29 Suppl 3(0 3):S221-S230. doi:10.1097/QAD.0000000000000924
· extracted · doi:10.1097/QAD.0000000000000924 · source:references/10665-360861.sec-030.57.jsonSanders EJ, Wahome E, Powers KA, Werner L, Fegan G, Lavreys L, et al. Targeted screening of at-risk adults for acute HIV-1 infection in sub-Saharan Africa. AIDS. 2015;29 Suppl 3(0 3):S221-S230. doi:10.1097/QAD.0000000000000924
- Issued
- 2015
- Type
- document
- DOI
- 10.1097/QAD.0000000000000924
- As printed
- Sanders EJ, Wahome E, Powers KA, Werner L, Fegan G, Lavreys L, et al. Targeted screening of at-risk adults for acute HIV-1 infection in sub-Saharan Africa. AIDS. 2015;29 Suppl 3(0 3):S221-S230. doi:10.1097/QAD.0000000000000924
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.57 - provenance: extracted
- read from
references/10665-360861.sec-030.57.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Phillips AN, Bershteyn A, Revill P, Bansi-Matharu L, Kripke K, Boily MC, et al. Cost– effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study. Lancet HIV. 2022;9(5):e353-e362. doi:10.1016/S2352-3018(22)00029-7
· extracted · doi:10.1016/S2352-3018(22)00029-7 · source:references/10665-360861.sec-030.58.jsonPhillips AN, Bershteyn A, Revill P, Bansi-Matharu L, Kripke K, Boily MC, et al. Cost– effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study. Lancet HIV. 2022;9(5):e353-e362. doi:10.1016/S2352-3018(22)00029-7
- Issued
- 2022
- Type
- article-journal
- DOI
- 10.1016/S2352-3018(22)00029-7
- As printed
- Phillips AN, Bershteyn A, Revill P, Bansi-Matharu L, Kripke K, Boily MC, et al. Cost– effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study. Lancet HIV. 2022;9(5):e353-e362. doi:10.1016/S2352-3018(22)00029-7
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.58 - provenance: extracted
- read from
references/10665-360861.sec-030.58.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Consolidated guidelines on HIV testing services, 2019. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1313903/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.59.jsonConsolidated guidelines on HIV testing services, 2019. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1313903/retrieve, accessed 29 June 2022).
- Issued
- 2020
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Consolidated guidelines on HIV testing services, 2019. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1313903/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.59 - provenance: extracted
- read from
references/10665-360861.sec-030.59.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Kerzner M, De AK, Yee R, Keating R, Djomand G, Stash S, et al. Pre-exposure prophylaxis (PrEP) uptake and service delivery adaptations during the first wave of the COVID-19 pandemic in 21 PEPFAR-funded countries. PLoS One. 2022;17(4):e0266280. doi:10.1371/journal.pone.0266280
· extracted · doi:10.1371/journal.pone.0266280 · source:references/10665-360861.sec-030.60.jsonKerzner M, De AK, Yee R, Keating R, Djomand G, Stash S, et al. Pre-exposure prophylaxis (PrEP) uptake and service delivery adaptations during the first wave of the COVID-19 pandemic in 21 PEPFAR-funded countries. PLoS One. 2022;17(4):e0266280. doi:10.1371/journal.pone.0266280
- Issued
- 2022
- Type
- article-journal
- DOI
- 10.1371/journal.pone.0266280
- As printed
- Kerzner M, De AK, Yee R, Keating R, Djomand G, Stash S, et al. Pre-exposure prophylaxis (PrEP) uptake and service delivery adaptations during the first wave of the COVID-19 pandemic in 21 PEPFAR-funded countries. PLoS One. 2022;17(4):e0266280. doi:10.1371/journal.pone.0266280
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.60 - provenance: extracted
- read from
references/10665-360861.sec-030.60.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Key considerations in developing policy guidance for differentiated PrEP service delivery: country policy development brief. Geneva: International AIDS Society; 2022 (https://www.differentiatedservicedelivery.org/Resources/Resource-Library/DSD-PrEP-policy-2022, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.61.jsonKey considerations in developing policy guidance for differentiated PrEP service delivery: country policy development brief. Geneva: International AIDS Society; 2022 (https://www.differentiatedservicedelivery.org/Resources/Resource-Library/DSD-PrEP-policy-2022, accessed 29 June 2022).
- Issued
- 2022
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Key considerations in developing policy guidance for differentiated PrEP service delivery: country policy development brief. Geneva: International AIDS Society; 2022 (https://www.differentiatedservicedelivery.org/Resources/Resource-Library/DSD-PrEP-policy-2022, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.61 - provenance: extracted
- read from
references/10665-360861.sec-030.61.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Tittle V, Dalton R, Nugent D, Girometti N, Whitlock G, Mcowan A, et al. Complex PrEP: the factors requiring consultant-led review of PrEP users. Sex Transm Infect. Published online February 15, 2022:sextrans-2021-055277. doi:10.1136/sextrans-2021-055277
· extracted · doi:10.1136/sextrans-2021-055277 · source:references/10665-360861.sec-030.62.jsonTittle V, Dalton R, Nugent D, Girometti N, Whitlock G, Mcowan A, et al. Complex PrEP: the factors requiring consultant-led review of PrEP users. Sex Transm Infect. Published online February 15, 2022:sextrans-2021-055277. doi:10.1136/sextrans-2021-055277
- Issued
- 2021
- Type
- document
- DOI
- 10.1136/sextrans-2021-055277
- As printed
- Tittle V, Dalton R, Nugent D, Girometti N, Whitlock G, Mcowan A, et al. Complex PrEP: the factors requiring consultant-led review of PrEP users. Sex Transm Infect. Published online February 15, 2022:sextrans-2021-055277. doi:10.1136/sextrans-2021-055277
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.62 - provenance: extracted
- read from
references/10665-360861.sec-030.62.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Velloza J, Schaefer R, Dalal S, Michelle R, Baggaley R. Evidence on acceptability, feasibility, and effectiveness of community-based delivery of HIV pre-exposure prophylaxis: results from a systematic review. Presented at: Adherence 2022, 11–13 July 2022, Washington, DC, USA.
· extracted · source:references/10665-360861.sec-030.63.jsonVelloza J, Schaefer R, Dalal S, Michelle R, Baggaley R. Evidence on acceptability, feasibility, and effectiveness of community-based delivery of HIV pre-exposure prophylaxis: results from a systematic review. Presented at: Adherence 2022, 11–13 July 2022, Washington, DC, USA.
- Issued
- 2022
- Type
- document
- As printed
- Velloza J, Schaefer R, Dalal S, Michelle R, Baggaley R. Evidence on acceptability, feasibility, and effectiveness of community-based delivery of HIV pre-exposure prophylaxis: results from a systematic review. Presented at: Adherence 2022, 11–13 July 2022, Washington, DC, USA.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-360861.sec-030.63 - provenance: extracted
- read from
references/10665-360861.sec-030.63.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Rousseau E, Bekker LG, Julies RF, Celum C, Morton J, Johnson R, et al. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa. BMC Health Serv Res. 2021;21(1):888. doi:10.1186/s12913-021-06920-4
· extracted · doi:10.1186/s12913-021-06920-4 · source:references/10665-360861.sec-030.64.jsonRousseau E, Bekker LG, Julies RF, Celum C, Morton J, Johnson R, et al. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa. BMC Health Serv Res. 2021;21(1):888. doi:10.1186/s12913-021-06920-4
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1186/s12913-021-06920-4
- As printed
- Rousseau E, Bekker LG, Julies RF, Celum C, Morton J, Johnson R, et al. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa. BMC Health Serv Res. 2021;21(1):888. doi:10.1186/s12913-021-06920-4
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.64 - provenance: extracted
- read from
references/10665-360861.sec-030.64.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Rosecrans A, Harris R, Saxton RE, Cotterell M, Zoltick M, Willman C, et al. Mobile low-threshold bupenorphrine integrated with infectious disease services. J Subst Abuse Treat. 2022;133. doi:10.1016/j.jsat.2021.108553
· extracted · doi:10.1016/j.jsat.2021.108553 · source:references/10665-360861.sec-030.65.jsonRosecrans A, Harris R, Saxton RE, Cotterell M, Zoltick M, Willman C, et al. Mobile low-threshold bupenorphrine integrated with infectious disease services. J Subst Abuse Treat. 2022;133. doi:10.1016/j.jsat.2021.108553
- Issued
- 2021
- Type
- document
- DOI
- 10.1016/j.jsat.2021.108553
- As printed
- Rosecrans A, Harris R, Saxton RE, Cotterell M, Zoltick M, Willman C, et al. Mobile low-threshold bupenorphrine integrated with infectious disease services. J Subst Abuse Treat. 2022;133. doi:10.1016/j.jsat.2021.108553
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.65 - provenance: extracted
- read from
references/10665-360861.sec-030.65.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Grammatico MA, Moll AP, Choi K, Springer SA, Shenoi S V. Feasibility of a community-based delivery model for HIV pre-exposure prophylaxis among bar patrons in rural South Africa. J Int AIDS Soc. 2021;24(11):e25848-e25848. doi:10.1002/jia2.25848
· extracted · doi:10.1002/jia2.25848 · source:references/10665-360861.sec-030.66.jsonGrammatico MA, Moll AP, Choi K, Springer SA, Shenoi S V. Feasibility of a community-based delivery model for HIV pre-exposure prophylaxis among bar patrons in rural South Africa. J Int AIDS Soc. 2021;24(11):e25848-e25848. doi:10.1002/jia2.25848
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1002/jia2.25848
- As printed
- Grammatico MA, Moll AP, Choi K, Springer SA, Shenoi S V. Feasibility of a community-based delivery model for HIV pre-exposure prophylaxis among bar patrons in rural South Africa. J Int AIDS Soc. 2021;24(11):e25848-e25848. doi:10.1002/jia2.25848
Sources
- doi:10.1002/jia2.25848 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.66 - provenance: extracted
- read from
references/10665-360861.sec-030.66.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Hoagland B, Torres TS, Bezerra DRB, Geraldo K, Pimenta C, Veloso VG, et al. Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil. Brazilian J Infect Dis. 2020;24(4):360-364. doi:10.1016/j.bjid.2020.05.004
· extracted · doi:10.1016/j.bjid.2020.05.004 · source:references/10665-360861.sec-030.67.jsonHoagland B, Torres TS, Bezerra DRB, Geraldo K, Pimenta C, Veloso VG, et al. Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil. Brazilian J Infect Dis. 2020;24(4):360-364. doi:10.1016/j.bjid.2020.05.004
- Issued
- 2020
- Type
- article-journal
- DOI
- 10.1016/j.bjid.2020.05.004
- As printed
- Hoagland B, Torres TS, Bezerra DRB, Geraldo K, Pimenta C, Veloso VG, et al. Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil. Brazilian J Infect Dis. 2020;24(4):360-364. doi:10.1016/j.bjid.2020.05.004
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.67 - provenance: extracted
- read from
references/10665-360861.sec-030.67.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Dourado I, Magno L, Soares F, Massa P, Nunn A, Dalal S, et al. Adapting to the COVID-19 pandemic: continuing HIV prevention services for adolescents through telemonitoring, Brazil. AIDS Behav. 2020;24(7):1994-1999. doi:10.1007/s10461-020-02927-w
· extracted · doi:10.1007/s10461-020-02927-w · source:references/10665-360861.sec-030.68.jsonDourado I, Magno L, Soares F, Massa P, Nunn A, Dalal S, et al. Adapting to the COVID-19 pandemic: continuing HIV prevention services for adolescents through telemonitoring, Brazil. AIDS Behav. 2020;24(7):1994-1999. doi:10.1007/s10461-020-02927-w
- Issued
- 2020
- Type
- article-journal
- DOI
- 10.1007/s10461-020-02927-w
- As printed
- Dourado I, Magno L, Soares F, Massa P, Nunn A, Dalal S, et al. Adapting to the COVID-19 pandemic: continuing HIV prevention services for adolescents through telemonitoring, Brazil. AIDS Behav. 2020;24(7):1994-1999. doi:10.1007/s10461-020-02927-w
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.68 - provenance: extracted
- read from
references/10665-360861.sec-030.68.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Hoagland B, Torres TS, Bezerra DRB, Benedetti M, Pimenta C, Veloso VG, et al. High acceptability of PrEP teleconsultation and HIV self-testing among PrEP users during the COVID-19 pandemic in Brazil. Brazilian J Infect Dis. 2021;25(1):101037. doi:10.1016/j.bjid.2020.11.002
· extracted · doi:10.1016/j.bjid.2020.11.002 · source:references/10665-360861.sec-030.69.jsonHoagland B, Torres TS, Bezerra DRB, Benedetti M, Pimenta C, Veloso VG, et al. High acceptability of PrEP teleconsultation and HIV self-testing among PrEP users during the COVID-19 pandemic in Brazil. Brazilian J Infect Dis. 2021;25(1):101037. doi:10.1016/j.bjid.2020.11.002
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1016/j.bjid.2020.11.002
- As printed
- Hoagland B, Torres TS, Bezerra DRB, Benedetti M, Pimenta C, Veloso VG, et al. High acceptability of PrEP teleconsultation and HIV self-testing among PrEP users during the COVID-19 pandemic in Brazil. Brazilian J Infect Dis. 2021;25(1):101037. doi:10.1016/j.bjid.2020.11.002
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.69 - provenance: extracted
- read from
references/10665-360861.sec-030.69.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Magno L. How to keep the innovation in the era of COVID-19 – Leaving adults out of the equation: using chatbots to provide interactive information to adolescents and young adults. Presented at: HIVR4P, 27–28 January & 3–4 February 2021, virtual (https://programme.hivr4p.org/Programme/Session/51, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.70.jsonMagno L. How to keep the innovation in the era of COVID-19 – Leaving adults out of the equation: using chatbots to provide interactive information to adolescents and young adults. Presented at: HIVR4P, 27–28 January & 3–4 February 2021, virtual (https://programme.hivr4p.org/Programme/Session/51, accessed 29 June 2022).
- Issued
- 2021
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Magno L. How to keep the innovation in the era of COVID-19 – Leaving adults out of the equation: using chatbots to provide interactive information to adolescents and young adults. Presented at: HIVR4P, 27–28 January & 3–4 February 2021, virtual (https://programme.hivr4p.org/Programme/Session/51, accessed 29 June 2022).
Sources
- programme.hivr4p.org/Programme/Session/51 (canonical)
In the knowledge graph
- IRI
references/10665-360861.sec-030.70 - provenance: extracted
- read from
references/10665-360861.sec-030.70.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Pascom A. Impact of COVID-19 pandemic on HIV care in Brazil. Presented at: CROI, 6–11 March 2021, virtual (https://www.croiconference.org/abstract/impact-of-covid-19-pandemic-on-hiv-care-in-brazil/, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.71.jsonPascom A. Impact of COVID-19 pandemic on HIV care in Brazil. Presented at: CROI, 6–11 March 2021, virtual (https://www.croiconference.org/abstract/impact-of-covid-19-pandemic-on-hiv-care-in-brazil/, accessed 29 June 2022).
- Issued
- 2021
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Pascom A. Impact of COVID-19 pandemic on HIV care in Brazil. Presented at: CROI, 6–11 March 2021, virtual (https://www.croiconference.org/abstract/impact-of-covid-19-pandemic-on-hiv-care-in-brazil/, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.71 - provenance: extracted
- read from
references/10665-360861.sec-030.71.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
The role of the pharmacist in self-care and self-medication. Geneva: World Health Organization; 1998 (https://apps.who.int/iris/handle/10665/65860, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.72.jsonThe role of the pharmacist in self-care and self-medication. Geneva: World Health Organization; 1998 (https://apps.who.int/iris/handle/10665/65860, accessed 29 June 2022).
- Issued
- 1998
- Type
- document
- Accessed
- 29 June 2022
- As printed
- The role of the pharmacist in self-care and self-medication. Geneva: World Health Organization; 1998 (https://apps.who.int/iris/handle/10665/65860, accessed 29 June 2022).
Sources
- apps.who.int/iris/handle/10665/65860 (canonical)
In the knowledge graph
- IRI
references/10665-360861.sec-030.72 - provenance: extracted
- read from
references/10665-360861.sec-030.72.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Ortblad KF, Mogere P, Bukusi E, Ngure K, Baeten JM. Pharmacy delivery to expand the reach of PrEP in Africa. J Int AIDS Soc. 2020;23(9):e25619. doi:10.1002/jia2.25619
· extracted · doi:10.1002/jia2.25619 · source:references/10665-360861.sec-030.73.jsonOrtblad KF, Mogere P, Bukusi E, Ngure K, Baeten JM. Pharmacy delivery to expand the reach of PrEP in Africa. J Int AIDS Soc. 2020;23(9):e25619. doi:10.1002/jia2.25619
- Issued
- 2020
- Type
- article-journal
- DOI
- 10.1002/jia2.25619
- As printed
- Ortblad KF, Mogere P, Bukusi E, Ngure K, Baeten JM. Pharmacy delivery to expand the reach of PrEP in Africa. J Int AIDS Soc. 2020;23(9):e25619. doi:10.1002/jia2.25619
Sources
- doi:10.1002/jia2.25619 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.73 - provenance: extracted
- read from
references/10665-360861.sec-030.73.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
WHO guideline on self-care interventions for health and well-being. Geneva: World Health Organization (https://apps.who.int/iris/rest/bitstreams/1440452/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.74.jsonWHO guideline on self-care interventions for health and well-being. Geneva: World Health Organization (https://apps.who.int/iris/rest/bitstreams/1440452/retrieve, accessed 29 June 2022).
- Type
- document
- Accessed
- 29 June 2022
- As printed
- WHO guideline on self-care interventions for health and well-being. Geneva: World Health Organization (https://apps.who.int/iris/rest/bitstreams/1440452/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.74 - provenance: extracted
- read from
references/10665-360861.sec-030.74.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Kennedy CE, Yeh PT, Atkins K, Ferguson L, Baggaley R, Narasimhan M. PrEP distribution in pharmacies: a systematic review. BMJ Open. 2022;12(2):e054121-e054121. doi:10.1136/bmjopen-2021-054121
· extracted · doi:10.1136/bmjopen-2021-054121 · source:references/10665-360861.sec-030.75.jsonKennedy CE, Yeh PT, Atkins K, Ferguson L, Baggaley R, Narasimhan M. PrEP distribution in pharmacies: a systematic review. BMJ Open. 2022;12(2):e054121-e054121. doi:10.1136/bmjopen-2021-054121
- Issued
- 2022
- Type
- article-journal
- DOI
- 10.1136/bmjopen-2021-054121
- As printed
- Kennedy CE, Yeh PT, Atkins K, Ferguson L, Baggaley R, Narasimhan M. PrEP distribution in pharmacies: a systematic review. BMJ Open. 2022;12(2):e054121-e054121. doi:10.1136/bmjopen-2021-054121
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.75 - provenance: extracted
- read from
references/10665-360861.sec-030.75.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Zhao A, Dangerfield DT, Nunn A, Patel R, Farley JE, Ugoji CC, et al. Pharmacy-based interventions to increase use of HIV pre-exposure prophylaxis in the United States: a scoping review. AIDS Behav. 2022;26(5):1377-1392. doi:10.1007/s10461-021-03494-4
· extracted · doi:10.1007/s10461-021-03494-4 · source:references/10665-360861.sec-030.76.jsonZhao A, Dangerfield DT, Nunn A, Patel R, Farley JE, Ugoji CC, et al. Pharmacy-based interventions to increase use of HIV pre-exposure prophylaxis in the United States: a scoping review. AIDS Behav. 2022;26(5):1377-1392. doi:10.1007/s10461-021-03494-4
- Issued
- 2022
- Type
- article-journal
- DOI
- 10.1007/s10461-021-03494-4
- As printed
- Zhao A, Dangerfield DT, Nunn A, Patel R, Farley JE, Ugoji CC, et al. Pharmacy-based interventions to increase use of HIV pre-exposure prophylaxis in the United States: a scoping review. AIDS Behav. 2022;26(5):1377-1392. doi:10.1007/s10461-021-03494-4
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.76 - provenance: extracted
- read from
references/10665-360861.sec-030.76.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Vanhamel J, Rotsaert A, Reyniers T, Nöstlinger C, Laga M, Van Landeghem E, et al. The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: a scoping review. BMC Health Serv Res. 2020;20(1):704. doi:10.1186/s12913-020-05568-w
· extracted · doi:10.1186/s12913-020-05568-w · source:references/10665-360861.sec-030.77.jsonVanhamel J, Rotsaert A, Reyniers T, Nöstlinger C, Laga M, Van Landeghem E, et al. The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: a scoping review. BMC Health Serv Res. 2020;20(1):704. doi:10.1186/s12913-020-05568-w
- Issued
- 2020
- Type
- article-journal
- DOI
- 10.1186/s12913-020-05568-w
- As printed
- Vanhamel J, Rotsaert A, Reyniers T, Nöstlinger C, Laga M, Van Landeghem E, et al. The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: a scoping review. BMC Health Serv Res. 2020;20(1):704. doi:10.1186/s12913-020-05568-w
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.77 - provenance: extracted
- read from
references/10665-360861.sec-030.77.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Schmidt HMA, Schaefer R, Nguyen VTT, Radebe M, Sued O, Rodolph M, et al. Scaling up access to HIV pre-exposure prophylaxis (PrEP): should nurses do the job? Lancet HIV. 2022;9(5):e363-e366. doi:10.1016/S2352-3018(22)00006-6
· extracted · doi:10.1016/S2352-3018(22)00006-6 · source:references/10665-360861.sec-030.78.jsonSchmidt HMA, Schaefer R, Nguyen VTT, Radebe M, Sued O, Rodolph M, et al. Scaling up access to HIV pre-exposure prophylaxis (PrEP): should nurses do the job? Lancet HIV. 2022;9(5):e363-e366. doi:10.1016/S2352-3018(22)00006-6
- Issued
- 2022
- Type
- article-journal
- DOI
- 10.1016/S2352-3018(22)00006-6
- As printed
- Schmidt HMA, Schaefer R, Nguyen VTT, Radebe M, Sued O, Rodolph M, et al. Scaling up access to HIV pre-exposure prophylaxis (PrEP): should nurses do the job? Lancet HIV. 2022;9(5):e363-e366. doi:10.1016/S2352-3018(22)00006-6
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.78 - provenance: extracted
- read from
references/10665-360861.sec-030.78.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Vannakit R, Janyam S, Linjongrat D, Chanlearn P, Sittikarn S, Pengnonyang S, et al. Give the community the tools and they will help finish the job: key population-led health services for ending AIDS in Thailand. J Int AIDS Soc. 2020;23(6):e25535. doi:10.1002/jia2.25535
· extracted · doi:10.1002/jia2.25535 · source:references/10665-360861.sec-030.79.jsonVannakit R, Janyam S, Linjongrat D, Chanlearn P, Sittikarn S, Pengnonyang S, et al. Give the community the tools and they will help finish the job: key population-led health services for ending AIDS in Thailand. J Int AIDS Soc. 2020;23(6):e25535. doi:10.1002/jia2.25535
- Issued
- 2020
- Type
- article-journal
- DOI
- 10.1002/jia2.25535
- As printed
- Vannakit R, Janyam S, Linjongrat D, Chanlearn P, Sittikarn S, Pengnonyang S, et al. Give the community the tools and they will help finish the job: key population-led health services for ending AIDS in Thailand. J Int AIDS Soc. 2020;23(6):e25535. doi:10.1002/jia2.25535
Sources
- doi:10.1002/jia2.25535 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.79 - provenance: extracted
- read from
references/10665-360861.sec-030.79.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Phanuphak N, Sungsing T, Jantarapakde J, Pengnonyang S, Trachunthong D, Mingkwanrungruang P, et al. Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand. Sex Health. 2018;15(6):542-555. doi:10.1071/sh18065
· extracted · doi:10.1071/sh18065 · source:references/10665-360861.sec-030.80.jsonPhanuphak N, Sungsing T, Jantarapakde J, Pengnonyang S, Trachunthong D, Mingkwanrungruang P, et al. Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand. Sex Health. 2018;15(6):542-555. doi:10.1071/sh18065
- Issued
- 2018
- Type
- article-journal
- DOI
- 10.1071/sh18065
- As printed
- Phanuphak N, Sungsing T, Jantarapakde J, Pengnonyang S, Trachunthong D, Mingkwanrungruang P, et al. Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand. Sex Health. 2018;15(6):542-555. doi:10.1071/sh18065
Sources
- doi:10.1071/sh18065 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.80 - provenance: extracted
- read from
references/10665-360861.sec-030.80.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Green KE, Nguyen LH, Phan HTT, Vu BN, Tran MH, Ngo H Van, et al. Prepped for PrEP? Acceptability, continuation and adherence among men who have sex with men and transgender women enrolled as part of Vietnam’s first pre-exposure prophylaxis program. Sex Health. 2021;18(1):104-115. doi:10.1071/SH20167
· extracted · doi:10.1071/SH20167 · source:references/10665-360861.sec-030.81.jsonGreen KE, Nguyen LH, Phan HTT, Vu BN, Tran MH, Ngo H Van, et al. Prepped for PrEP? Acceptability, continuation and adherence among men who have sex with men and transgender women enrolled as part of Vietnam’s first pre-exposure prophylaxis program. Sex Health. 2021;18(1):104-115. doi:10.1071/SH20167
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1071/SH20167
- As printed
- Green KE, Nguyen LH, Phan HTT, Vu BN, Tran MH, Ngo H Van, et al. Prepped for PrEP? Acceptability, continuation and adherence among men who have sex with men and transgender women enrolled as part of Vietnam’s first pre-exposure prophylaxis program. Sex Health. 2021;18(1):104-115. doi:10.1071/SH20167
Sources
- doi:10.1071/SH20167 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.81 - provenance: extracted
- read from
references/10665-360861.sec-030.81.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Matambanadzo P, Busza J, Mafaune H, Chinyanganya L, Machingura F, Ncube G, et al. “It went through the roof”: an observation study exploring the rise in PrEP uptake among Zimbabwean female sex workers in response to adaptations during Covid-19. J Int AIDS Soc. 2021;24(S6):e25813. doi:10.1002/jia2.25813
· extracted · doi:10.1002/jia2.25813 · source:references/10665-360861.sec-030.82.jsonMatambanadzo P, Busza J, Mafaune H, Chinyanganya L, Machingura F, Ncube G, et al. “It went through the roof”: an observation study exploring the rise in PrEP uptake among Zimbabwean female sex workers in response to adaptations during Covid-19. J Int AIDS Soc. 2021;24(S6):e25813. doi:10.1002/jia2.25813
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1002/jia2.25813
- As printed
- Matambanadzo P, Busza J, Mafaune H, Chinyanganya L, Machingura F, Ncube G, et al. “It went through the roof”: an observation study exploring the rise in PrEP uptake among Zimbabwean female sex workers in response to adaptations during Covid-19. J Int AIDS Soc. 2021;24(S6):e25813. doi:10.1002/jia2.25813
Sources
- doi:10.1002/jia2.25813 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.82 - provenance: extracted
- read from
references/10665-360861.sec-030.82.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Bailey LE, Siberry GK, Agaba P, Douglas M, Clinkscales JR, Godfrey C. The impact of COVID-19 on multi-month dispensing (MMD) policies for antiretroviral therapy (ART) and MMD uptake in 21 PEPFAR-supported countries: a multi-country analysis. J Int AIDS Soc. 2021;24(S6):e25794. doi:10.1002/jia2.25794
· extracted · doi:10.1002/jia2.25794 · source:references/10665-360861.sec-030.83.jsonBailey LE, Siberry GK, Agaba P, Douglas M, Clinkscales JR, Godfrey C. The impact of COVID-19 on multi-month dispensing (MMD) policies for antiretroviral therapy (ART) and MMD uptake in 21 PEPFAR-supported countries: a multi-country analysis. J Int AIDS Soc. 2021;24(S6):e25794. doi:10.1002/jia2.25794
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1002/jia2.25794
- As printed
- Bailey LE, Siberry GK, Agaba P, Douglas M, Clinkscales JR, Godfrey C. The impact of COVID-19 on multi-month dispensing (MMD) policies for antiretroviral therapy (ART) and MMD uptake in 21 PEPFAR-supported countries: a multi-country analysis. J Int AIDS Soc. 2021;24(S6):e25794. doi:10.1002/jia2.25794
Sources
- doi:10.1002/jia2.25794 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.83 - provenance: extracted
- read from
references/10665-360861.sec-030.83.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
A rapid assessment of multi-month dispensing of antiretroviral treatment and pre-exposure prophylaxis [in] the Asia-Pacific region. Bangkok: UNAIDS Regional Office for Asia and the Pacific; 2020 (https://www.aidsdatahub.org/sites/default/files/resource/unaids-ap-rapid-assessment-mmd-implementation-asia-and-pacific-2020.pdf, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.84.jsonA rapid assessment of multi-month dispensing of antiretroviral treatment and pre-exposure prophylaxis [in] the Asia-Pacific region. Bangkok: UNAIDS Regional Office for Asia and the Pacific; 2020 (https://www.aidsdatahub.org/sites/default/files/resource/unaids-ap-rapid-assessment-mmd-implementation-asia-and-pacific-2020.pdf, accessed 29 June 2022).
- Issued
- 2020
- Type
- document
- Accessed
- 29 June 2022
- As printed
- A rapid assessment of multi-month dispensing of antiretroviral treatment and pre-exposure prophylaxis [in] the Asia-Pacific region. Bangkok: UNAIDS Regional Office for Asia and the Pacific; 2020 (https://www.aidsdatahub.org/sites/default/files/resource/unaids-ap-rapid-assessment-mmd-implementation-asia-and-pacific-2020.pdf, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.84 - provenance: extracted
- read from
references/10665-360861.sec-030.84.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Rapid guidance on HIV service delivery in COVID-19 context. Harare: Zimbabwe Ministry of Health and Child Care; 2020
· extracted · source:references/10665-360861.sec-030.85.jsonRapid guidance on HIV service delivery in COVID-19 context. Harare: Zimbabwe Ministry of Health and Child Care; 2020
- Issued
- 2020
- Type
- document
- As printed
- Rapid guidance on HIV service delivery in COVID-19 context. Harare: Zimbabwe Ministry of Health and Child Care; 2020
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-360861.sec-030.85 - provenance: extracted
- read from
references/10665-360861.sec-030.85.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Ngure K. Six-month PrEP with HIV self-testing to improve delivery Kenya: a randomized trial. Presented at: CROI, 12–16 February 2022, virtual (https://www.croiconference.org/abstract/six-month-prep-with-hiv-self-testing-to-improve-delivery-kenya-a-randomized-trial/, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.86.jsonNgure K. Six-month PrEP with HIV self-testing to improve delivery Kenya: a randomized trial. Presented at: CROI, 12–16 February 2022, virtual (https://www.croiconference.org/abstract/six-month-prep-with-hiv-self-testing-to-improve-delivery-kenya-a-randomized-trial/, accessed 29 June 2022).
- Issued
- 2022
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Ngure K. Six-month PrEP with HIV self-testing to improve delivery Kenya: a randomized trial. Presented at: CROI, 12–16 February 2022, virtual (https://www.croiconference.org/abstract/six-month-prep-with-hiv-self-testing-to-improve-delivery-kenya-a-randomized-trial/, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.86 - provenance: extracted
- read from
references/10665-360861.sec-030.86.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Sewell WC, Powell VE, Ball-Burack M, Mayer KH, Ochoa A, Marcus JL, et al. Brief report: “i didn’t really have a primary care provider until I got PrEP”: patients’ perspectives on HIV preexposure prophylaxis as a gateway to health care. J Acquir Immune Defic Syndr. 2021;88(1):31-35. doi:10.1097/QAI.0000000000002719
· extracted · doi:10.1097/QAI.0000000000002719 · source:references/10665-360861.sec-030.87.jsonSewell WC, Powell VE, Ball-Burack M, Mayer KH, Ochoa A, Marcus JL, et al. Brief report: “i didn’t really have a primary care provider until I got PrEP”: patients’ perspectives on HIV preexposure prophylaxis as a gateway to health care. J Acquir Immune Defic Syndr. 2021;88(1):31-35. doi:10.1097/QAI.0000000000002719
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1097/QAI.0000000000002719
- As printed
- Sewell WC, Powell VE, Ball-Burack M, Mayer KH, Ochoa A, Marcus JL, et al. Brief report: “i didn’t really have a primary care provider until I got PrEP”: patients’ perspectives on HIV preexposure prophylaxis as a gateway to health care. J Acquir Immune Defic Syndr. 2021;88(1):31-35. doi:10.1097/QAI.0000000000002719
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.87 - provenance: extracted
- read from
references/10665-360861.sec-030.87.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Phanuphak N, Ramautarsing R, Chinbunchorn T, Janamnuaysook R, Pengnonyang S, Termvanich K, et al. Implementing a status-neutral approach to HIV in the Asia-Pacific. Curr HIV/AIDS Rep. 2020;17(5):422-430. doi:10.1007/s11904-020-00516-z
· extracted · doi:10.1007/s11904-020-00516-z · source:references/10665-360861.sec-030.88.jsonPhanuphak N, Ramautarsing R, Chinbunchorn T, Janamnuaysook R, Pengnonyang S, Termvanich K, et al. Implementing a status-neutral approach to HIV in the Asia-Pacific. Curr HIV/AIDS Rep. 2020;17(5):422-430. doi:10.1007/s11904-020-00516-z
- Issued
- 2020
- Type
- article-journal
- DOI
- 10.1007/s11904-020-00516-z
- As printed
- Phanuphak N, Ramautarsing R, Chinbunchorn T, Janamnuaysook R, Pengnonyang S, Termvanich K, et al. Implementing a status-neutral approach to HIV in the Asia-Pacific. Curr HIV/AIDS Rep. 2020;17(5):422-430. doi:10.1007/s11904-020-00516-z
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.88 - provenance: extracted
- read from
references/10665-360861.sec-030.88.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Myers JE, Braunstein SL, Xia Q, Scanlin K, Edelstein Z, Harriman G, et al. Redefining prevention and care: a status-neutral approach to HIV. Open Forum Infect Dis. 2018;5(6):ofy097-ofy097. doi:10.1093/ofid/ofy097
· extracted · doi:10.1093/ofid/ofy097 · source:references/10665-360861.sec-030.89.jsonMyers JE, Braunstein SL, Xia Q, Scanlin K, Edelstein Z, Harriman G, et al. Redefining prevention and care: a status-neutral approach to HIV. Open Forum Infect Dis. 2018;5(6):ofy097-ofy097. doi:10.1093/ofid/ofy097
- Issued
- 2018
- Type
- article-journal
- DOI
- 10.1093/ofid/ofy097
- As printed
- Myers JE, Braunstein SL, Xia Q, Scanlin K, Edelstein Z, Harriman G, et al. Redefining prevention and care: a status-neutral approach to HIV. Open Forum Infect Dis. 2018;5(6):ofy097-ofy097. doi:10.1093/ofid/ofy097
Sources
- doi:10.1093/ofid/ofy097 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.89 - provenance: extracted
- read from
references/10665-360861.sec-030.89.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Integration of mental health and HIV interventions – Key considerations. Geneva: Joint United Nations Programme on HIV/AIDS; World Health Organization; 2022 (https://www.unaids.org/en/resources/documents/2022/integration-mental-health-hiv-interventions, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.90.jsonIntegration of mental health and HIV interventions – Key considerations. Geneva: Joint United Nations Programme on HIV/AIDS; World Health Organization; 2022 (https://www.unaids.org/en/resources/documents/2022/integration-mental-health-hiv-interventions, accessed 29 June 2022).
- Issued
- 2022
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Integration of mental health and HIV interventions – Key considerations. Geneva: Joint United Nations Programme on HIV/AIDS; World Health Organization; 2022 (https://www.unaids.org/en/resources/documents/2022/integration-mental-health-hiv-interventions, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.90 - provenance: extracted
- read from
references/10665-360861.sec-030.90.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
van Griensven F, Janamnuaysook R, Nampaisan O, Peelay J, Samitpol K, Mills S, et al. Uptake of primary care services and HIV and syphilis infection among transgender women attending the Tangerine Community Health Clinic, Bangkok, Thailand, 2016–2019. J Int AIDS Soc. 2021;24(6):e25683-e25683. doi:10.1002/jia2.25683
· extracted · doi:10.1002/jia2.25683 · source:references/10665-360861.sec-030.91.jsonvan Griensven F, Janamnuaysook R, Nampaisan O, Peelay J, Samitpol K, Mills S, et al. Uptake of primary care services and HIV and syphilis infection among transgender women attending the Tangerine Community Health Clinic, Bangkok, Thailand, 2016–2019. J Int AIDS Soc. 2021;24(6):e25683-e25683. doi:10.1002/jia2.25683
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1002/jia2.25683
- As printed
- van Griensven F, Janamnuaysook R, Nampaisan O, Peelay J, Samitpol K, Mills S, et al. Uptake of primary care services and HIV and syphilis infection among transgender women attending the Tangerine Community Health Clinic, Bangkok, Thailand, 2016–2019. J Int AIDS Soc. 2021;24(6):e25683-e25683. doi:10.1002/jia2.25683
Sources
- doi:10.1002/jia2.25683 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.91 - provenance: extracted
- read from
references/10665-360861.sec-030.91.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Sevelius J. Factors affecting PrEP uptake and time to initiation among transgender participants in the TRIUMPH PrEP demonstration project in Oakland and Sacramento, California. Presented at: 23rd International AIDS Conference, 6–10 July 2020, San Francisco (virtual) (http://programme.aids2020.org/Abstract/Abstract/3391, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.92.jsonSevelius J. Factors affecting PrEP uptake and time to initiation among transgender participants in the TRIUMPH PrEP demonstration project in Oakland and Sacramento, California. Presented at: 23rd International AIDS Conference, 6–10 July 2020, San Francisco (virtual) (http://programme.aids2020.org/Abstract/Abstract/3391, accessed 29 June 2022).
- Issued
- 2020
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Sevelius J. Factors affecting PrEP uptake and time to initiation among transgender participants in the TRIUMPH PrEP demonstration project in Oakland and Sacramento, California. Presented at: 23rd International AIDS Conference, 6–10 July 2020, San Francisco (virtual) (http://programme.aids2020.org/Abstract/Abstract/3391, accessed 29 June 2022).
Sources
- programme.aids2020.org/Abstract/Abstract/3391 (canonical)
In the knowledge graph
- IRI
references/10665-360861.sec-030.92 - provenance: extracted
- read from
references/10665-360861.sec-030.92.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Green K. Transforming PrEP in Vietnam: rethinking service delivery to enhance access among transgender women. Presented at: 23rd International AIDS Conference, 6–10 July 2020, San Francisco, CA, USA (virtual) (http://programme.aids2020.org/Programme/Session/71, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.93.jsonGreen K. Transforming PrEP in Vietnam: rethinking service delivery to enhance access among transgender women. Presented at: 23rd International AIDS Conference, 6–10 July 2020, San Francisco, CA, USA (virtual) (http://programme.aids2020.org/Programme/Session/71, accessed 29 June 2022).
- Issued
- 2020
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Green K. Transforming PrEP in Vietnam: rethinking service delivery to enhance access among transgender women. Presented at: 23rd International AIDS Conference, 6–10 July 2020, San Francisco, CA, USA (virtual) (http://programme.aids2020.org/Programme/Session/71, accessed 29 June 2022).
Sources
- programme.aids2020.org/Programme/Session/71 (canonical)
In the knowledge graph
- IRI
references/10665-360861.sec-030.93 - provenance: extracted
- read from
references/10665-360861.sec-030.93.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Preventing HIV and other STIs among women and girls using contraceptive services in contexts with high HIV incidence. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1279661/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.94.jsonPreventing HIV and other STIs among women and girls using contraceptive services in contexts with high HIV incidence. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1279661/retrieve, accessed 29 June 2022).
- Issued
- 2020
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Preventing HIV and other STIs among women and girls using contraceptive services in contexts with high HIV incidence. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1279661/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.94 - provenance: extracted
- read from
references/10665-360861.sec-030.94.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Mugwanya KK, Pintye J, Kinuthia J, Abuna F, Lagat H, Begnel ER, et al. Integrating preexposure prophylaxis delivery in routine family planning clinics: a feasibility programmatic evaluation in Kenya. PLOS Med. 2019;16(9):e1002885. doi:10.1371/journal.pmed.1002885
· extracted · doi:10.1371/journal.pmed.1002885 · source:references/10665-360861.sec-030.95.jsonMugwanya KK, Pintye J, Kinuthia J, Abuna F, Lagat H, Begnel ER, et al. Integrating preexposure prophylaxis delivery in routine family planning clinics: a feasibility programmatic evaluation in Kenya. PLOS Med. 2019;16(9):e1002885. doi:10.1371/journal.pmed.1002885
- Issued
- 2019
- Type
- article-journal
- DOI
- 10.1371/journal.pmed.1002885
- As printed
- Mugwanya KK, Pintye J, Kinuthia J, Abuna F, Lagat H, Begnel ER, et al. Integrating preexposure prophylaxis delivery in routine family planning clinics: a feasibility programmatic evaluation in Kenya. PLOS Med. 2019;16(9):e1002885. doi:10.1371/journal.pmed.1002885
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.95 - provenance: extracted
- read from
references/10665-360861.sec-030.95.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Wanga V, Peebles K, Obiero A, Mogaka F, Omollo V, Odoyo JB, et al. Cost of pre-exposure prophylaxis delivery in family planning clinics to prevent HIV acquisition among adolescent girls and young women in Kisumu, Kenya. PLoS One. 2021;16(4):e0249625-e0249625. doi:10.1371/journal.pone.0249625
· extracted · doi:10.1371/journal.pone.0249625 · source:references/10665-360861.sec-030.96.jsonWanga V, Peebles K, Obiero A, Mogaka F, Omollo V, Odoyo JB, et al. Cost of pre-exposure prophylaxis delivery in family planning clinics to prevent HIV acquisition among adolescent girls and young women in Kisumu, Kenya. PLoS One. 2021;16(4):e0249625-e0249625. doi:10.1371/journal.pone.0249625
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1371/journal.pone.0249625
- As printed
- Wanga V, Peebles K, Obiero A, Mogaka F, Omollo V, Odoyo JB, et al. Cost of pre-exposure prophylaxis delivery in family planning clinics to prevent HIV acquisition among adolescent girls and young women in Kisumu, Kenya. PLoS One. 2021;16(4):e0249625-e0249625. doi:10.1371/journal.pone.0249625
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.96 - provenance: extracted
- read from
references/10665-360861.sec-030.96.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Bhavaraju N, Wilcher R, Regeru RN, Mullick S, Mahaka I, Rodrigues J, et al. Integrating oral PrEP into family planning services for women in sub-Saharan Africa: findings from a multi-country landscape analysis. Front Reprod Health. 2021;3. doi:10.3389/frph.2021.667823
· extracted · doi:10.3389/frph.2021.667823 · source:references/10665-360861.sec-030.97.jsonBhavaraju N, Wilcher R, Regeru RN, Mullick S, Mahaka I, Rodrigues J, et al. Integrating oral PrEP into family planning services for women in sub-Saharan Africa: findings from a multi-country landscape analysis. Front Reprod Health. 2021;3. doi:10.3389/frph.2021.667823
- Issued
- 2021
- Type
- document
- DOI
- 10.3389/frph.2021.667823
- As printed
- Bhavaraju N, Wilcher R, Regeru RN, Mullick S, Mahaka I, Rodrigues J, et al. Integrating oral PrEP into family planning services for women in sub-Saharan Africa: findings from a multi-country landscape analysis. Front Reprod Health. 2021;3. doi:10.3389/frph.2021.667823
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.97 - provenance: extracted
- read from
references/10665-360861.sec-030.97.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Ong JJ, Baggaley RC, Wi TE, Tucker JD, Fu H, Smith MK, et al. Global epidemiologic characteristics of sexually transmitted infections among individuals using preexposure prophylaxis for the prevention of HIV infection: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(12):e1917134-e1917134. doi:10.1001/jamanetworkopen.2019.17134
· extracted · doi:10.1001/jamanetworkopen.2019.17134 · source:references/10665-360861.sec-030.98.jsonOng JJ, Baggaley RC, Wi TE, Tucker JD, Fu H, Smith MK, et al. Global epidemiologic characteristics of sexually transmitted infections among individuals using preexposure prophylaxis for the prevention of HIV infection: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(12):e1917134-e1917134. doi:10.1001/jamanetworkopen.2019.17134
- Issued
- 2019
- Type
- article-journal
- DOI
- 10.1001/jamanetworkopen.2019.17134
- As printed
- Ong JJ, Baggaley RC, Wi TE, Tucker JD, Fu H, Smith MK, et al. Global epidemiologic characteristics of sexually transmitted infections among individuals using preexposure prophylaxis for the prevention of HIV infection: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(12):e1917134-e1917134. doi:10.1001/jamanetworkopen.2019.17134
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.98 - provenance: extracted
- read from
references/10665-360861.sec-030.98.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Prevention and control of sexually transmitted infections (STIs) in the era of oral pre-exposure prophylaxis (PrEP) for HIV. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/rest/bitstreams/1238572/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.99.jsonPrevention and control of sexually transmitted infections (STIs) in the era of oral pre-exposure prophylaxis (PrEP) for HIV. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/rest/bitstreams/1238572/retrieve, accessed 29 June 2022).
- Issued
- 2019
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Prevention and control of sexually transmitted infections (STIs) in the era of oral pre-exposure prophylaxis (PrEP) for HIV. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/rest/bitstreams/1238572/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.99 - provenance: extracted
- read from
references/10665-360861.sec-030.99.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1315304/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.100.jsonGlobal strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1315304/retrieve, accessed 29 June 2022).
- Issued
- 2020
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1315304/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.100 - provenance: extracted
- read from
references/10665-360861.sec-030.100.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Ong JJ, Fu H, Baggaley RC, Wi TE, Tucker JD, Smith MK, et al. Missed opportunities for sexually transmitted infections testing for HIV pre-exposure prophylaxis users: a systematic review. J Int AIDS Soc. 2021;24(2):e25673. doi:10.1002/jia2.25673
· extracted · doi:10.1002/jia2.25673 · source:references/10665-360861.sec-030.101.jsonOng JJ, Fu H, Baggaley RC, Wi TE, Tucker JD, Smith MK, et al. Missed opportunities for sexually transmitted infections testing for HIV pre-exposure prophylaxis users: a systematic review. J Int AIDS Soc. 2021;24(2):e25673. doi:10.1002/jia2.25673
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1002/jia2.25673
- As printed
- Ong JJ, Fu H, Baggaley RC, Wi TE, Tucker JD, Smith MK, et al. Missed opportunities for sexually transmitted infections testing for HIV pre-exposure prophylaxis users: a systematic review. J Int AIDS Soc. 2021;24(2):e25673. doi:10.1002/jia2.25673
Sources
- doi:10.1002/jia2.25673 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.101 - provenance: extracted
- read from
references/10665-360861.sec-030.101.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
WHO information note on the use of dual HIV/syphilis rapid diagnostic tests (RDT). Geneva: World Health Organization; 2017 (https://apps.who.int/iris/bitstream/handle/10665/252849/WHO-RHR-17.01-eng.pdf?sequence=1, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.102.jsonWHO information note on the use of dual HIV/syphilis rapid diagnostic tests (RDT). Geneva: World Health Organization; 2017 (https://apps.who.int/iris/bitstream/handle/10665/252849/WHO-RHR-17.01-eng.pdf?sequence=1, accessed 29 June 2022).
- Issued
- 2017
- Type
- document
- Accessed
- 29 June 2022
- As printed
- WHO information note on the use of dual HIV/syphilis rapid diagnostic tests (RDT). Geneva: World Health Organization; 2017 (https://apps.who.int/iris/bitstream/handle/10665/252849/WHO-RHR-17.01-eng.pdf?sequence=1, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.102 - provenance: extracted
- read from
references/10665-360861.sec-030.102.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Dual HIV/syphilis rapid diagnostic tests can be used as the first test in antenatal care. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/rest/bitstreams/1261480/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.103.jsonDual HIV/syphilis rapid diagnostic tests can be used as the first test in antenatal care. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/rest/bitstreams/1261480/retrieve, accessed 29 June 2022).
- Issued
- 2019
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Dual HIV/syphilis rapid diagnostic tests can be used as the first test in antenatal care. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/rest/bitstreams/1261480/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.103 - provenance: extracted
- read from
references/10665-360861.sec-030.103.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Guidelines for the management of symptomatic sexually transmitted infections. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/rest/bitstreams/1355614/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.104.jsonGuidelines for the management of symptomatic sexually transmitted infections. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/rest/bitstreams/1355614/retrieve, accessed 29 June 2022).
- Issued
- 2021
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Guidelines for the management of symptomatic sexually transmitted infections. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/rest/bitstreams/1355614/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.104 - provenance: extracted
- read from
references/10665-360861.sec-030.104.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Self-collection of samples for sexually transmitted infections (STIs). Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1280120/retrieve, accessed 29 June 2022).
· extracted · link · source:references/10665-360861.sec-030.105.jsonSelf-collection of samples for sexually transmitted infections (STIs). Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1280120/retrieve, accessed 29 June 2022).
- Issued
- 2020
- Type
- document
- Accessed
- 29 June 2022
- As printed
- Self-collection of samples for sexually transmitted infections (STIs). Geneva: World Health Organization; 2020 (https://apps.who.int/iris/rest/bitstreams/1280120/retrieve, accessed 29 June 2022).
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.105 - provenance: extracted
- read from
references/10665-360861.sec-030.105.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Kersh EN, Shukla M, Raphael BH, Habel M, Park I. At-home specimen self-collection and self-testing for sexually transmitted infection screening demand accelerated by the COVID-19 pandemic: a review of laboratory implementation issues. J Clin Microbiol. 2022;59(11):e02646-20. doi:10.1128/JCM.02646-20
· extracted · doi:10.1128/JCM.02646-20 · source:references/10665-360861.sec-030.106.jsonKersh EN, Shukla M, Raphael BH, Habel M, Park I. At-home specimen self-collection and self-testing for sexually transmitted infection screening demand accelerated by the COVID-19 pandemic: a review of laboratory implementation issues. J Clin Microbiol. 2022;59(11):e02646-20. doi:10.1128/JCM.02646-20
- Issued
- 2022
- Type
- article-journal
- DOI
- 10.1128/JCM.02646-20
- As printed
- Kersh EN, Shukla M, Raphael BH, Habel M, Park I. At-home specimen self-collection and self-testing for sexually transmitted infection screening demand accelerated by the COVID-19 pandemic: a review of laboratory implementation issues. J Clin Microbiol. 2022;59(11):e02646-20. doi:10.1128/JCM.02646-20
Sources
- doi:10.1128/JCM.02646-20 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.106 - provenance: extracted
- read from
references/10665-360861.sec-030.106.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Hiransuthikul A, Janamnuaysook R, Himma L, Taya C, Amatsombat T, Chumnanwet P, et al. Acceptability and satisfaction towards self-collection for chlamydia and gonorrhoea testing among transgender women in Tangerine Clinic, Thailand: shifting towards the new normal. J Int AIDS Soc. 2021;24(9):e25801-e25801. doi:10.1002/jia2.25801
· extracted · doi:10.1002/jia2.25801 · source:references/10665-360861.sec-030.107.jsonHiransuthikul A, Janamnuaysook R, Himma L, Taya C, Amatsombat T, Chumnanwet P, et al. Acceptability and satisfaction towards self-collection for chlamydia and gonorrhoea testing among transgender women in Tangerine Clinic, Thailand: shifting towards the new normal. J Int AIDS Soc. 2021;24(9):e25801-e25801. doi:10.1002/jia2.25801
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1002/jia2.25801
- As printed
- Hiransuthikul A, Janamnuaysook R, Himma L, Taya C, Amatsombat T, Chumnanwet P, et al. Acceptability and satisfaction towards self-collection for chlamydia and gonorrhoea testing among transgender women in Tangerine Clinic, Thailand: shifting towards the new normal. J Int AIDS Soc. 2021;24(9):e25801-e25801. doi:10.1002/jia2.25801
Sources
- doi:10.1002/jia2.25801 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.107 - provenance: extracted
- read from
references/10665-360861.sec-030.107.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Grimshaw C, Boyd L, Smith M, Estcourt CS, Metcalfe R. Evaluation of an inner city HIV pre-exposure prophylaxis service tailored to the needs of people who inject drugs. HIV Med. 2021;22(10):965-970. doi:10.1111/hiv.13181
· extracted · doi:10.1111/hiv.13181 · source:references/10665-360861.sec-030.108.jsonGrimshaw C, Boyd L, Smith M, Estcourt CS, Metcalfe R. Evaluation of an inner city HIV pre-exposure prophylaxis service tailored to the needs of people who inject drugs. HIV Med. 2021;22(10):965-970. doi:10.1111/hiv.13181
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1111/hiv.13181
- As printed
- Grimshaw C, Boyd L, Smith M, Estcourt CS, Metcalfe R. Evaluation of an inner city HIV pre-exposure prophylaxis service tailored to the needs of people who inject drugs. HIV Med. 2021;22(10):965-970. doi:10.1111/hiv.13181
Sources
- doi:10.1111/hiv.13181 (doi)
In the knowledge graph
- IRI
references/10665-360861.sec-030.108 - provenance: extracted
- read from
references/10665-360861.sec-030.108.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
McAuley A, Palmateer NE, Goldberg DJ, Trayner KMA, Shepherd SJ, Gunson RN, et al. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis. Lancet HIV. 2019;6(5):e315-e324. doi:10.1016/S2352-3018(19)30036-0
· extracted · doi:10.1016/S2352-3018(19)30036-0 · source:references/10665-360861.sec-030.109.jsonMcAuley A, Palmateer NE, Goldberg DJ, Trayner KMA, Shepherd SJ, Gunson RN, et al. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis. Lancet HIV. 2019;6(5):e315-e324. doi:10.1016/S2352-3018(19)30036-0
- Issued
- 2019
- Type
- article-journal
- DOI
- 10.1016/S2352-3018(19)30036-0
- As printed
- McAuley A, Palmateer NE, Goldberg DJ, Trayner KMA, Shepherd SJ, Gunson RN, et al. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis. Lancet HIV. 2019;6(5):e315-e324. doi:10.1016/S2352-3018(19)30036-0
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.109 - provenance: extracted
- read from
references/10665-360861.sec-030.109.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Metcalfe R, Ragonnet-Cronin M, Bradley-Stewart A, McAuley A, Stubbs H, Ritchie T, et al. From hospital to the community: redesigning the human immunodeficiency virus (HIV) clinical service model to respond to an outbreak of HIV among people who inject drugs. J Infect Dis. 2020;222(Suppl 5):S410-S419. doi:10.1093/infdis/jiaa336
· extracted · doi:10.1093/infdis/jiaa336 · source:references/10665-360861.sec-030.110.jsonMetcalfe R, Ragonnet-Cronin M, Bradley-Stewart A, McAuley A, Stubbs H, Ritchie T, et al. From hospital to the community: redesigning the human immunodeficiency virus (HIV) clinical service model to respond to an outbreak of HIV among people who inject drugs. J Infect Dis. 2020;222(Suppl 5):S410-S419. doi:10.1093/infdis/jiaa336
- Issued
- 2020
- Type
- document
- DOI
- 10.1093/infdis/jiaa336
- As printed
- Metcalfe R, Ragonnet-Cronin M, Bradley-Stewart A, McAuley A, Stubbs H, Ritchie T, et al. From hospital to the community: redesigning the human immunodeficiency virus (HIV) clinical service model to respond to an outbreak of HIV among people who inject drugs. J Infect Dis. 2020;222(Suppl 5):S410-S419. doi:10.1093/infdis/jiaa336
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.110 - provenance: extracted
- read from
references/10665-360861.sec-030.110.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md
-
Smith M, Elliott L, Hutchinson SJ, Metcalfe R, Flowers P, McAuley A. Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an HIV outbreak: a qualitative study. Int J Drug Policy. 2021;88:103033. doi:10.1016/j.drugpo.2020.103033
· extracted · doi:10.1016/j.drugpo.2020.103033 · source:references/10665-360861.sec-030.111.jsonSmith M, Elliott L, Hutchinson SJ, Metcalfe R, Flowers P, McAuley A. Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an HIV outbreak: a qualitative study. Int J Drug Policy. 2021;88:103033. doi:10.1016/j.drugpo.2020.103033
- Issued
- 2021
- Type
- article-journal
- DOI
- 10.1016/j.drugpo.2020.103033
- As printed
- Smith M, Elliott L, Hutchinson SJ, Metcalfe R, Flowers P, McAuley A. Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an HIV outbreak: a qualitative study. Int J Drug Policy. 2021;88:103033. doi:10.1016/j.drugpo.2020.103033
Sources
In the knowledge graph
- IRI
references/10665-360861.sec-030.111 - provenance: extracted
- read from
references/10665-360861.sec-030.111.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-360861/sections/sec-030-references.md